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– Abstract –  
 
Rhodium(III)-Catalyzed Difunctionalization of Alkenes 
Initiated by Carbon–Hydrogen Bond Activation 
 
Erik J. T. Phipps 
 
The direct conversion of carbon–hydrogen bonds into valuable carbon-carbon 
and carbon-heteroatom bonds is a significant challenge to synthetic organic chemists. 
More than ever, chemists are employing Rh(III)-catalysts bearing cyclopentadienyl 
(Cp) ligands to transform otherwise inert C–H bonds. Furthermore, manipulating the 
sterics and electronics of the Cp ligand show significant impact on catalytic 
transformations. Our group has developed a library of CpXRh(III)-precatalysts in hopes 
of enhancing known reactivity as well as discovering new C–H bond functionalizations. 
We have previously reported that N-enoxyphthalimides are a unique one-carbon 
component for the cyclopropanation of activated alkenes. In an effort to expand the 
scope to accessible alkenes, we have found a number of symmetrical unactivated 
alkenes undergo [2+1] annulation to afford intriguing spirocyclic cyclopropanes. 
Additionally, we have developed a Rh(III)-catalyzed diastereoselective [2+1] 
annulation onto allylic alcohols to furnish substituted cyclopropyl ketones. Notably, 
the traceless oxyphthalimide handle serves three functions: directing C–H activation, 
oxidation of Rh(III), and, collectively with the allylic alcohol, in directing 
cyclopropanation to control diastereoselectivity. Allylic alcohols are shown to be highly 
reactive olefin coupling partners leading to a directed diastereoselective 
cyclopropanation reaction, providing products not accessible by other routes. 
Next, an artifact of previous cyclopropanation reactions leads to the formation of 
a Rh-π-allyl complex. Attempts at 1,1-carboamination of alkenes are made using 
alkenes and nitrenoid precursors toward the 3-component synthesis of allylic amines. 
Stoichiometric studies help elucidate the mechanism and challenges.  
Lastly, efforts toward 1,2-carboamination of alkenes initiated by sp3 C–H bond 
activation are made with two different reactivity manifolds. Isolation of reaction 
intermediates are discussed as well as providing viable paths toward valuable products. 
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– Chapter One – 
Introduction to CpXRh(III)-catalyzed C–H Activation 
 
1.1 Importance of C–H Functionalization 
The direct conversion of carbon–hydrogen bonds into valuable carbon-
carbon and carbon-heteroatom bonds is a significant challenge to synthetic 
organic chemists.1 Carbon–Hydrogen bonds are the most common motifs in 
small molecules, and due to this ubiquity, this makes C–H bonds among the 
most desirable candidates to be manipulated and transformed into valuable 
targets. The high bond dissociation energy (BDE) presents the first challenge. 
Compared to that of pre-functionalized analogues such as aryl halides (Figure 
1.1) C–H bonds are significantly more inert. 
 
Figure 1.1 Characteristics in the diversity of C–H bonds in organic synthesis. 
When considering C–H bonds, their high pKa value compared to that of 
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a method that has gained significant traction in the field of organic synthesis 
throughout the years is metal-catalyzed C–H bond activation. 
 
1.2 Modes of C–H Activation 
Predominately, there are two pathways to break a C–H bond and form a 
new metal-carbon bond as an intermediate. 
 
Figure 1.2 Modes of C–H bond activation to furnish new carbon-metal bonds. 
The first is oxidative addition, where the metal center is formally oxidized 
by 2 electrons to both a metal-carbon bond and a metal-hydride bond. The 
second pathway involves a ligand-assisted deprotonation event named concerted 
metallation-deprotonation (CMD). This pathway often involves weak bases with 
κ2 binding modes (such as carboxylates, carbonates, phosphates, etc.) and is 
















Pathway 1: Oxidative Addition
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agostic interaction to acidify the C–H bond, enabling a 6-membered transition 
state for deprotonation and subsequent metalation of the carbon unit. Each 
mode of reactivity provides advantages and disadvantages; but on the whole, 
CMD tends to be a much milder method to functionalize C–H bonds. 
 
1.3 Installation of Directing Groups 
 While C–H bonds can be activated in a number of ways, the challenge of 
selectively cleaving a specific bond remains.  
In order to combat this challenge, chemists install directing groups with 
heteroatoms that put the metal in close proximity to the C–H bond to be 
activated. This strategy relies heavily on confirmation of resulting metallacyclic 
species for further functionalization to occur. 
 
Figure 1.3 Selectivity challenges of C–H activation. 
Among other metals, rhodium(III) piano stool complexes bearing a 
cyclopentadienyl (Cp) ligand have shown great selectivity and diversity in 
functionalization methods in recent years. In association with a carboxylate-type 
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3 coordination sites beneath the Cp ligand to selectively convert a C–H bond 
into more important motifs such as C–C, C–N, C–O bonds.3 
 
Figure 1.4 Directing group assisted Rh(III)-catalyzed ortho-C–H functionalization. 
 
In 2010, our group joined the community and took advantage of this 
reactivity by treating secondary benzamides with alkynes in the presence of 
copper(II) acetate and a rhodium(III) catalyst bearing a 
pentamethylcyclopentadiene (Cp*) ligand.4 First the dimer pre-catalyst is broken 
up to liberate the Rh-diacetato active catalyst. This species can deprotonate the 
N–H bond of the benzamide revealing a directing group toward the ortho-C–H 
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gives rise to a 5-membered metallacycle. After migratory insertion affords the 7-
membered metallacycle, reductive elimination forms a C–N bond and gives the 
isoquinolone product. Finally, 2 equivalents of CuII oxidize the resulting RhI 
species to regenerate the catalyst. 
 






































































Rovis 2010: Oxidative Cyclization of Benzamides and Alkynes via C–H/N–H Activation
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Around the same time, Fagnou and coworkers published a similar 
reaction with the installation of an internal oxidant as opposed to exogenous, 
stoichiometric amounts of copper(II) acetate.5 This reactivity manifold allows for 
the same benzannulation to occur under milder conditions. Fagnou and 
coworkers then optimized the oxidative directing group from –OMe to –OPiv.6 
This alteration allows for the chemistry to happen at room temperature as well 
as expanding its scope to the insertion of alkenes, giving dihydroisoquinolones. 
 
Figure 1.6 Installation of internal oxidant for the oxidative cyclization of benzamides with 
alkenes and alkynes. 
 
 
1.4 Mechanistic Considerations 
Mechanistically, this system is proposed to work by N–H deprotonation, 



























Fagnou 2010: Installation of Internal Oxidant
Fagnou 2011: Optimization of Internal Oxidant
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followed by oxidative addition of the N–O bond. Finally, protodemetallation 
furnishes the product and regenerates the catalyst. 
 
Figure 1.7 Proposed mechanism of alkene/alkyne benzannulation with an internal oxidant. 
Fagnou’s addition of the internal oxidant was revolutionary to Rh(III)-
catalyzed C–H activation and alkene difunctionalization. While this proposed 
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have given new insights. 7  The major difference comes from the C–N bond 
forming event being reductive or oxidative in nature.  
 
Figure 1.8 Proposed oxidative nitrene formation.  
In the oxidative pathway, a metal-nitrene is formed by formal oxidation of 
the Rh center. The idea of oxidative induced reductive elimination has gained 
popularity in recent years among transition metal-catalyzed reactions.8 In this 
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have had an impact on my own research as well as the field, as seen in the 
chapters to come. 
 
1.5 Tuning Cyclopentadienyl Ligands to Impact Catalysis 
 Fundamental studies in the field of Rh(III)-catalyzed C–H activation have 
deployed Cp* as the parent cyclopentadienyl ligand.  In metal-catalyzed 
reactions, the choice of ligand on the metal affects each step in the catalytic 
cycle, influencing reactivity and/or selectivity. In the past decade, our group and 
others have concocted a library of Cp ligands with varying electronic and steric 
properties on Rh complexes (figure 1.9).9 Employing these modified Cp ligands 
as pre-catalysts has affected the reactivity and selectivity the catalysts show in 
the synthesis of small molecules.10 
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Figure 1.9 Selected examples of modified cyclopentadienyl ligands. 
 
1.6 Summary 
 The direct conversion of carbon–hydrogen bonds into valuable carbon-
carbon and carbon-heteroatom bonds is a significant challenge to synthetic 
organic chemists. More than ever, chemists are employing Rh(III)-catalysts 
bearing cyclopentadienyl (Cp) ligands to transform otherwise inert C–H bonds. 
Furthermore, manipulating the sterics and electronics of the Cp ligand has 
R
Electronically Tuned Cp Ligands




t-Bu t-Bu R = t-Bu       Cyi-Pr
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CyCpCpTM CptriPh or CptetraPh
CpT Cpi-Pr Cp*t-Bu or Cp*Cy
Cp*diPh
CpE Cp*CF3 Cp*bisCF3
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significant impact on catalytic transformations. Our group and others have 
developed a library of CpXRh(III)-precatalysts in hopes of enhancing known 
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– Chapter Two – 
Rh(III)-catalyzed Cyclopropanation of 
Unactivated Alkenes Initiated by C–H Activation 
 
2.1 Introduction to Cyclopropanation 
 The synthesis of cyclopropane-containing molecules has intrigued synthetic 
organic chemists for years because of their prevalence in synthetic targets1 as well as 
their susceptibility as reactive intermediates.2   
 
Figure 2.1 Selected examples of cyclopropane units in natural product synthesis. 
Preferably, cyclopropane ring construction would be an intermolecular reaction 
involving a 1-carbon unit adding to a 2-carbon unit which is formally a [2+1] annulation. 
The simplest 2-carbon units for use in the synthesis are alkenes. Generally, when probing 
for new reactivity using an alkene, chemists tend to start with activated alkenes bearing 
an electron withdrawing or donating group to help polarize the alkene. Alkenes bearing 
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Furthermore, starting alkene geometry can translate to stereodefined cyclopropane 
products. 
 
Figure 2.2 General protocol for the synthesis of cyclopropanes from alkenes. 
Regarding the 1-carbon units, carbene precursors are known to be effective due to  
A plethora of robust methods have been developed to afford cyclopropane motifs 
from alkenes. Generally, Simmons-Smith and diazo decomposition are regarded as the 
two most powerful methods for the cyclopropanation of alkenes.3, 4 Simmons-Smith type 
reactions are well-established to afford cyclopropanes from the generation of a zinc-
carbenoid species that interacts with unactivated olefins with high stereoselectivity; 
however, these methods are limited by the substitution pattern of the carbenoid reagent5 
and the stoichiometric use of zinc.6 Regarding unactivated olefins, Uyeda and coworkers 
noted that under standard Simmons-Smith type conditions, cyclopropanation of non-
conjugated dienes is moderate in yield and only moderately selective for the terminal 
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distinguish between the two alkenes and perform in good yield. Uyeda demonstrated the 
power of this method on a number of similar unactivated alkenes. 
 
Figure 2.3 Simmons-Smith reactivity with unactivated alkenes. 
Metal-catalyzed diazo decomposition has also provided complimentary reactivity 
to access stereodefined cyclopropanes with a more diverse substitution pattern albeit 
with two notable shortcomings. While numerous methods have been established for Rh-
catalyzed cyclopropanation of alkenes,8 many of these methods require the use of high-
energy diazo compounds.9 Davies and coworkers have been arguably the biggest 
influence on this chemistry for decades. Cyclopropanation of unactivated alkenes using 
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Notably, Davies and coworkers employed a Rh(II) catalyst bearing protected proline 
ligand to impart enantioselectivity on the transformation.10 These Rh(II) catalysts with 
other chiral ligands have cemented themselves to the field of metal-carbene transfer 
chemistry. Interestingly, to date, Fürstner and coworkers published the only example 
Rh(III)-catalyzed cyclopropanation of styrene type alkenes from diazo one-carbon 
components. 
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2.2 Reactivity Profile of N-enoxyimides 
 N-Enoxyphthalimides constitute valuable alternatives to potentially explosive 
diazo compounds and pyrophoric organozinc reagents due to the mild conditions and 
the allure of C–H functionalization reactions (Figure 1).11 Our initial report in 2014 
showed that aryl N-enoxyphthalimides undergo C–H activation and smoothly undergo 
[2+1] annulation with activated olefins bearing electron withdrawing groups, affording 
trans-cyclopropanes in good yield and diastereoselectivity.12 
 
Figure 2.5 Trans-Cyclopropanation. 
 Importantly, the mechanism first described does not propose the formation of a 
metal-carbene species. Instead, two migratory insertion events are thought to give rise 
to the trans-cyclopropane. From deuterium labeling studies scrambling is observed alpha 
to the ketone, indicating a reversible event during the catalytic cycle. To account for this, 
beta-hydride elimination is proposed to be reversible by Rh–H deprotonation. Due to the 
high pKa measured of Cp*Rh–H species,13 this event is unlikely with acetate base as the 
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In a follow-up report, we demonstrated that tuning the electronic properties of 
the Cp ligand as well as the phthalimide ring affords access to the cis-cyclopropane 
scaffold.14 
 
Figure 2.7 Cis-Cyclopropanation. 
Here, the change in selectivity is proposed to arise by phthalimide ring opening 
by the alcoholic solvent.   
Cramer and coworker have rendered the trans-cyclopropanation reaction 
asymmetric by employing their chiral Cp ligand to provide trans-cyclopropanes in high 
e.r.15 Additionally, they were able to expand the scope of the one-carbon unit beyond aryl 
substituents. 
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In an effort to expand the scope of this transformation, we set out to examine 
stereodefined cyclopropanation of unactivated olefins. 
 
Figure 2.9 Proposed Rh(III)-catalyzed cyclopropanation of unactivated alkenes from N-
enoxyphthalimides  
 
2.3 Reaction Optimization 
 From the trans-cyclopropanation study, our group found that 1,1-dialkylalkenes 
undergo cyclopropanation in modest yield. The shortcoming in this transformation is 
the reaction is unselective with [Cp*RhCl2]2 precatalyst. 
 
Figure 2.10 Original hit with Cp*Rh(III) precatalyst. 
 Because of the large library of CpXRh(III) precatalysts our group has built we 
predicted that by tuning the sterics and/or electronics of the Cp ligand, we could impart 
selectivity in cyclopropanation of unactivated alkenes. After screening 15+ ligands, we 
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ligands improve the yield of the reaction. In particular, Cp*CF3 gives the highest yield of 
82%.  
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Due to the lack of diastereoselectivity imparted by the Cp ligand we chose to 
advance the project with symmetrical 1,1-disubstituted alkenes in the presence of 
Cp*CF3Rh(III) catalyst. 
 
2.4 Scope of the Cyclopropanation Reaction 
We began by examining 3-methylenepentane as a coupling partner and found 
modest reactivity as cyclopropane 2-3aa was afforded in 40% yield. A number of 
exocyclic alkenes proved to be excellent participants in this reaction giving a wide range 
of [2.n]spirocyclic ketones. We interrogated the effect of different size carbocycles 
ranging from 4 to 8-membered rings (2-3ab to 2-3af). Notably, methylenecyclohexane 
gives [2.5]spirocycle 2-3ad in near quantitative yield. Both tosyl- and Boc-protected 
methylene piperidines display good reactivity affording cyclopropane 2-3ag in 72% and 
2-3ah in 89% yield, respectively. Cyclopropanation of a methylene cyclohexane bearing 
a substituent at the 4-position proceeds efficiently, delivering cyclopropane 2-3ai in 97% 
yield and good diastereoselectivity (8.6:1 d.r.).16 
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Scheme 2.2 Scope of 1,1-disubstituted alkenes. 
Varying para- (2-3bd to 2-3dd) and meta- (2-3ed to 2-3gd) arene substitution on 
the enoxyphthalimide is tolerated, with each substrate displaying excellent yields. ortho-
Fluorine containing enoxyphthalimide delivers cyclopropane 2-3hd in 59% yield. 
Naphthyl enoxyphthalimide gives cyclopropane 2-3id in 67% yield. Finally, an alkyl 
substituted N-enoxyphthalimide is also a competent substrate, affording cyclopropane 
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Scheme 2.3 Scope of N-enoxyphthalimides. 
 While these examples display a nice range of functional group tolerance, 
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2.5 Participation of Other Alkenes 
 We also surveyed the reactivity pattern of different alkenes: 
Knowing the cyclopropane 2-3aj is formed in good yield but unselective, we tried to 
increase the steric load by changing n-Bu to i-Pr and saw a dramatic drop in yield, with 
poor diastereoselectivity. Styrene gives the desired cyclopropane in good yield but poor 
d.r. Gratifyingly, we see the related unactivated alkene, 1-decene gives cyclopropane 2-
3am in moderate yield as well. Vinyl acetate does not participate in the cyclopropanation 
reaction; however, the related electron-rich alkene 2,3-dihydrofuran gives cyclopropane 
2-3ao in low yield. Similarly, the locked cis alkene cyclopentene and the related trans-4-
octene proceed in low yield. Interestingly, norbornene provides tricycle 2-3ar in 
moderate yield and importantly as a single diastereomer. Combining what we know from 
the performance of 1,1-disubstituted alkenes and styrenes, we were disappointed that a-
methyl styrene does not participate in the cyclopropanation reaction. However, 
introducing a methylene spacer restores moderate reactivity and 1:1 diastereoselectivity. 
Finally, similar to substrate 2-3aa, we see that extending the chain using 5-
methylenenonane drops reactivity to 12% yield. 
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Scheme 2.4 Scope of alkenes with varying substitution. 
 
2.6 Mechanistic Studies 
Finally, we sought to interrogate the mechanism of this reaction (Figure 4). 
Subjecting 2-1a to the reaction conditions using TFE-d1 leads to no deuterium 
incorporation upon re-isolation of 2-1a. In another experiment, we subjected 2-1a and 
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yield.  From the analysis of the product, we observe a reversible deuterium exchange 
event at the alpha-position (54% D incorporation). 
 
Figure 2.11 Deuterium labeling studies. 
 We next probed the role of the phthalimide ring by subjecting 2-1a to 2 equiv. of 
CsOAc in TFE and observed the formation of dioxazoline 2-4 in 59% yield, indicating 
TFE opens the phthalimide ring. We believe the resulting amide is a key intermediate to 
direct the catalyst for the C–H activation step; however, attempts to isolate the opened 
phthalimide were unsuccesful. Finally, we subjected 2-4 to 2-2d and the reaction 
conditions. However, only trace product was observed indicating 2-4 does not 
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2.7 Proposed Mechanism 
 On the basis of these experiments, we propose the following mechanism: 
 
 
Figure 2.30 Proposed Mechanism. 
First, the precatalyst undergoes salt metathesis with CsOAc to form the active 
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before dioxazoline 2-4 formation, and undergoes C–H activation via concerted 
metalation-deprotonation to afford intermediate III. At this stage, we believe 
intermediate III displays enolic character to reversibly wash in deuterium before ligand 
exchange of 2-2. After exchanging acetic acid for alkene that gives intermediate V, we 
propose the formation of a Rh-carbene, intermediate V, via cleavage of the N–O bond. 
Intermediate V then gives way to the desired cyclopropane product. 
 
2.8 Summary 
In conclusion, we have developed a Rh(III)-catalyzed cyclopropanation protocol 
for N-enoxyphthalimides and unactivated olefins. The N-enoxyphthalimide has been 
shown to undergo C–H activation that leads to a proposed metal-carbene to induce a 
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– Chapter Three – 
Rh(III)-catalyzed C–H Activation-Initiated 
Directed Cyclopropanation of Allylic Alcohols 
 
3.1 Cyclopropanation of Allylic Alcohols 
 Biological and synthetic targets containing cyclopropane units have intrigued 
organic chemists for years as a result of their unique properties and the synthetic 
challenges.1 A number of powerful methods have been developed for the stereoselective 
synthesis of cyclopropane motifs.2 These methods largely share a common approach of 
an alkene that undergoes a [2+1] annulation with carbenes, metal carbenes, or metal-
carbenoid species. In particular, allylic alcohols have been exploited as coupling partners 
in cyclopropanation reactions for their leverageable, pendent hydroxyl group. Ultimately, 
this handle provides regio- and diastereoselective cyclopropanations. Two methods have 
emerged as preferred techniques for the cyclopropanation of alkenes: Simmons-Smith 
type reactions and catalyzed diazo decompositions. 
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Figure 3.1 General strategies for the cyclopropanation of allylic alcohols. 
The Simmons-Smith approach features stoichiometric zinc reagents to aid both the 
formation and transfer of carbenoid species from simple methylene sources. Similarly, 
metal-catalyzed diazo decomposition is a broadly powerful reactivity manifold for the 
cyclopropanation of alkenes, with Rh,3 Ru,4 Pd,5 Cu,6 Co,7 and Fe8 catalysts utilized for 
their carbenoid formation and transfer capabilities. Notably, both modes of reactivity 
have also been rendered asymmetric when using prochiral alkenes.9 Charette has 
implemented strategies for enantioselective cyclopropanation of unprotected allylic 
alcohols by employing chiral diamine ligands or catalytic Ti bearing a taddolate ligand 
for chirality transfer. Additionally, in the realm of asymmetric cyclopropanation, metal 
catalysts (Cu and Rh shown below) bearing chiral ligands have been used to decompose 
diazo compounds and undergo [2+1] annulation with protected allylic alcohols in 
stereoselective fashion. Here it is necessary for the allylic alcohol to be protected to 
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Figure 3.2 State-of-the-Art strategies for cyclopropanation of allylic alcohol-type alkenes. 
 With regards to allylic alcohols, notable shortcomings have arisen in the two 
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diastereoselective, it is largely limited to methylenation10 Charette has shown that pre-
functionalizing substituted methylene-zinc precursors allows for some functional groups 
to be carried through the cyclopropanation reaction. However, the substitution pattern 
of the one-carbon unit is limited to iodo- and boryl-functionalized units. In the case of 
metal-catalyzed diazo decomposition, the cyclopropanation of allyl alcohol is low 
yielding and instead O–H insertion is observed as the major product. Because the metal-
carbene species is electrophilic, the pendant hydroxyl group reacts much faster than the 
alkene. 
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We have previously reported that N-enoxyphthalimides are a unique one-carbon 
component for the cyclopropanation of activated alkenes.11 Furthermore, tuning the 
cyclopentadienyl (Cp) ligand on the RhIII catalyst delivers either cis- or trans-disubstituted 
cyclopropanes stereoselectively.12, 13 In a complementary approach, we found that by 
exchanging trifluoroethanol (TFE) solvent for methanol (MeOH) and again tuning the 
Cp ligand on the Rh catalyst, activated alkenes undergo syn-1,2-carboamination.14  
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This chemodivergence is hypothesized to originate from MeOH participating as a 
nucleophile to open the phthalimide ring that allows the N-enoxyphthalimide to act as a 
bidentate ligand throughout catalysis. On the basis of these findings, we sought to 
expand the scope of our reported diastereoselective cyclopropanation toward unactivated 
alkenes. 
 
Figure 3.5 Proposed Rh(III)-catalyzed directed cyclopropanation of allylic alcohols. 
 
3.2 Reaction Optimization  
Initial investigations began with phenyl-N-enoxyphthalimide 3-1a and trans-2-
hexen-1-ol 3-2a in the presence of various Rh(III) catalysts in TFE at room temperature 
delivering cyclopropane 3aa in moderate yield but high diastereoselectivities. Ultimately, 
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Figure 3.6 Cp ligand optimization. 
Solvent (entries B and C) and base screens revealed that KOPiv in TFE is optimal, 
providing 64% yield and >20:1 d.r. for the desired product (entry D). Our next thought 
was to heat the reaction to push it to completion; however, we observed only 11% yield 
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leads to the desired cyclopropane in 81% yield while preserving excellent 
diastereoselectivity (entry F). 
 
Scheme 3.1 Reaction optimization–Examination of the effects of inorganic bases, solvents, and 
temperature. 
	
3.3 Stereoselectivity of the Cyclopropanation Reaction 
We next examined if the diastereoselectivity of the tri-substituted cyclopropane 
product was directly correlated with initial alkene geometry (Scheme 2). Both trans- and 
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and 3-3ab in good yield–81% and 62%, respectively–and >20:1 d.r., implicating a 
stereospecific transformation. 
 
Figure 3.7 Primary allylic alcohols bearing a trans or cis disubstituted alkene.  
 
3.4 Scope of the Cyclopropanation Reaction 
Similar to the parent allylic alcohol, we found crotyl alcohol gives cyclopropane 
3-3ac in excellent diastereoselectivity and 81% yield. Methallyl alcohol gives 
cyclopropane 3-3ad in 62% yield with 7:1 d.r. while prenyl alcohol furnishes 3-3ae in 
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Scheme 3.2 Scope of primary allylic alcohols. 
With optimized conditions in hand, we examined the scope of this reaction 
(Scheme 3). Varying para- (3-3ba-3-3ea) and meta- (3-3fa-3-3ha) arene substitution on 
the enoxyphthalimide is tolerated, with each substrate displaying >20:1 
diastereoselectivity. Ortho-Fluorine containing enoxyphthalimide delivers cyclopropane 
3-3ia in 44% yield. Alkyl substituted N-enoxyphthalimide15 is also a competent 
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Scheme 3.3 Scope of N-enoxyphthalimides. 
Next, a range of suitable allylic alcohols for the cyclopropanation reaction was 
explored (Scheme 4). Notably, chiral allylic alcohol substrates provide additional 
complexity leading to the potential of four different stereoisomers. In the event, these 
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diastereoselectivity depending on the substituent size, from vinyl (73%, 2.5:1 d.r., major 
to S minor), to methyl (69%, 7.1:1 d.r.) and phenyl (62%, >20:1 d.r.). Using trans-1,2-
disubstituted secondary allylic alcohols, we observed single diastereomers of 
cyclopropanes 3-3aj-3-3al ranging in good to excellent yields. 
 
 
Scheme 3.4 Scope of secondary allylic alcohols. 
Interestingly, when our cyclopropanation protocol was applied to secondary, 
cyclic allylic alcohols, the results revealed a divergence in the mechanism. Using 
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cyclopropane product was not observed. However, when cyclooctenol was used the 
corresponding cyclopropane was observed in 85% yield as a single diastereomer. This 
set of experiments revealed a few points about the mechanism of this reaction. On the 
basis of the crystal structure of 3-3ah, we confirmed the anti-addition of the carbene 
transfer. Under Simmons-Smith reaction conditions, similar selectivities are observed 
for syn-addition to cyclohexenol and anti-addition to cyclooctenol. It is hypothesized 
using cyclooctenol, the eight-membered ring prefers to adapt a chair-boat confirmation 
with the complexed hydroxyl group in the equatorial position, allowing methylene 
transfer to easily be delivered to the closes face of the alkene in anti fashion as a single 
diastereomer. In our system, we propose the hydroxyl group is not directly complexed 
to the metal; however, since it is linked through phthalimide opening, the methyle 
transfer still prefers anti-addition. 
 
	- 48 - 
 









OH OH OHHHH H
CH2I2
Zn-Cu couple
74%; 0.5 : 99.5
syn anti








































Simmons-Smith Model Our Model
- Selectivites of cyclic allylic alcohols under Simmons-Smith conditions
	- 49 - 
3.5 Mechanistic Studies 
To interrogate the mechanism of this cyclopropanation reaction (Scheme 5), we 
first tested the length of the nucleophilic tether. Homoallylic alcohol 3-4a gives 
cyclopropane 3-5aa in only 12% yield indicating the chain length from the oxygen atom 
to the olefin is of great importance. Similarily, bis-homoallylic alcohol 3-6a gives 
cyclopropane 3-7aa in only 17% yield. 
To showcase the regio-preference of our cyclopropanation protocol, 3-1a was 
subjected to substrate 3-2m (geraniol) bearing a tethered tri-substituted alkene as a 
potential competitive site for cyclopropanation. Gratifyingly, cyclopropane 3-3am was 
generated in 55% yield with good diastereoselectivity and excellent regioselectivity. 
Nerol, the cis isomer, also gave the desired cyclopropane 3-3an in lower yield but similar 
selectivities to geraniol. With these studies, we conclude that our cyclopropanation 
protocol is regioselective. 
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Figure 3.9 Regioselective applications of the cyclopropanation protocol. 
Next, we sought to test if the tethered nucleophile was needed for reactivity. 
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presence of an unhindered hydroxyl-group is necessary for the reaction to take place. 
Allylic carboxylic acid 3-8b gives cyclopropane 3-9ab in trace yield. Interestingly, 
protected allylic amine 3-8c gives cyclopropane 3-9ac in 77% yield and 9.5:1 d.r. From 
these experiements, we conclude that a nucleophilic attack is necessary for reactivity. 
The lack of reactivity with allylic ethers clearly shows this. Trace formation of 3-9ab 
could be due to reduced nucleophilicity of carboxylates; however, addition of a carboxylic 
acid buffers the solution. From optimization reactions, 2 equivalents of base is needed 
for this transformation to proceed. When reactivity is restored using a pendant 
sulfonamide, we believe this functional group is nucleophilic enough to open the 
phthalimide ring and does not affect the concentration of base present in the reaction. 
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Figure 3.10 Investigations of the nucleophilicity of the allylic functional group. 
 We next subjected 3-1a to the reaction conditions in the absence of alkene with 
TFE-d1 solvent and observed no deuteration of the alkenyl protons suggesting that the 
C–H activation is irreversible. Using a deuterium labeled allylic alcohol at the alkene, we 
again observe a stereospecific transformation as the desired cyclopropane is observed in 
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Figure 3.11 Deuterium labeling studies. 
In another experiment, we set out to detect potential reactivity between 3-1a and 
3-2b in the absence of Rh catalyst and we were surprised to observe the formation of 
dioxazoline 3-10ac in 38% yield with 1 equivalent of KOPiv in THF at room temperature. 
We speculate this occurs via opening of the phthalimide ring and acylation of the allylic 
alcohol (eq. 8). Subjecting dioxazoline 3-10ac to the cyclopropanation reaction 
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Figure 3.12 Observation and intermediacy test of dioxazoline. 
Furthermore, dioxazoline 3-10ac is observed while monitoring the reaction by crude 1H-
NMR (Appendix Two), indicating, that the phthalimide ring is opened during the 
reaction and not upon workup. 
From these studies, we conclude that the cyclopropanation reaction: 1) is 
regioselective, 2) is conformationally dependent, 3) requires a tethered nucleophile, and 
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3.6 Proposed Mechanism 
 On the basis of these experiments, we propose the following mechanism (Scheme 
6). First, 3-2 undergoes acylation with 3-1 that gives intermediate I. Maintaining the 
reaction temperature at 0 °C inhibits cyclization to afford the dioxazoline product, which 
is instead intercepted by the active Rh(III) catalyst II. Intermediate I undergoes N–H 
deprotonation that gives intermediate III to initiate an irreversible C–H activation via 
concerted metalation-deprotonation that results in rhodacycle IV. At this stage, we 
hypothesize the formation of intermediate V by cleavage of the N–O bond and formation 
of a Rh-carbene. Due to the prior acylation of the allylic alcohol, intermediate VI is 
formed via the [2+1] annulation where the Rh-carbene is delivered across the alkene 
and on the same face as the pendent oxygen atom in stereoselective fashion.  
Protodemetallation and subsequent phthalimide ring closure releases the product and 
turns the catalyst over. 
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3.7 Summary 
 In conclusion, we have developed a directed diastereoselective cyclopropanation 
protocol for the [2+1] annulation of N-enoxyphthalimides and allylic alcohols. The 
diastereoselectivity of the reaction is speculated to arise from an intermediate generated 
by a ring-opening acylation of the allylic alcohol. Generation of a Rh-carbenoid leads to 
intramolecular cyclopropanation in excellent yield and diastereoselectivity. 
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– Chapter Four – 
Validating Isolated Reaction Intermediates 
for 1,1-Carboamination of N-enoxyphthalimides 
 
4.1 Artifacts of the Cyclopropanation Reaction 
 While probing the scope of cyclopropanation of unactivated alkenes, we subjected 
4-1a to the standard reaction conditions under an atmosphere of ethylene. We found 
complete consumption of starting material but only trace desired cyclopropane 4-3aa. 
 
Figure 4.1 Cyclopropanation reaction with ethylene as the alkene. 
 After purification, we observed the formation of a Rh-π-allyl complex in 83% 
yield. This was further confirmed by X-ray crystallography.  
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 Similar to the mechanism described in chapters 2 and 3, we believe 4-4 is provided 
by CMD-type C–H activation of N-enoxyphthalimides. After migratory insertion, a 7-
membered rhodacycle is likely formed. From here, the π-allyl species observed can be 
furnished by a number of transformations. The pathway we favor involves a beta-hydride 
elimination that gives a Rh-hydride that can undergo sigma bond metathesis to cleave  
the N–O bond. After Rh-enolate isomerization and ligand substitutions, 4-4 is formed. 
Overall, this is a redox-neutral process, so the Rh-center may remain Rh(III) at all times. 
However, the Rh could undergo earlier oxidation (via cleavage of the N–O bond) or 
reduction (likely by deprotonation of a metal-hydride). 
 
Figure 4.3 Likely pathway for the formation of 4-4. 
 We first wanted to evaluate if 4-4 played a role in the cyclopropanation of 
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presence of CsOAc and TFE at room temperature. We found that cyclopropane 4-3ab is 
afforded in 9% yield, which is dramatically lower than the µ-dichloride precatalyst.  
 
Figure 4.4 Subjection of 4-4 to cyclopropanation reaction conditions. 
 While we observed turnover with 4-4 as the catalyst in the cyclopropanation of 
4-2a, we wanted to leverage the formation of a π-allyl species to furnish a new bond. 
 
4.2 Overview of C–N Bond Formation from π-Allyl Species from Nitrenoid 
Precursors 
 Building on previous success in CpXIr(III)-catalyzed transformations,1 our group 
first reported the branched-selective allylic amination of terminal alkenes from 
dioxazolones. In the presence of LiOAc, Ag-salt, and Cp*Ir(III) catalyst, terminal alkenes 
undergo allylic C–H activation to afford h-3 Ir-π-allyl complexes. Importantly, the 
isolable π-allyl complexes can be converted to the desired allylic amide when subjected 
to dioxazolone.2 It is suggested that the Ir-π-allyl complex is oxidized by cleavage of the 
N–O bond that affords a Ir-nitrene. The resulting Ir(V)-nitrene then undergoes fast 
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Figure 4.5 Ir(III)-catalyzed intermolecular branched-selective allylic amination of terminal alkenes. 
 Soon after, Glorius and coworkers expanded the scope to include internal alkenes 
with minimal changes to the reaction conditions.3 
 
Figure 4.6 Intermolecular amination of internal alkenes. 
 Blakey and coworkers also reported on the Ir-catalyzed branched-selective allylic 
amination in a report the same year.4 Interestingly, they found that in the presence of 
catalytic CsOAc and Ag-salt in DCE at 40 °C, simply switching from an Ir to a Rh 
precatalyst diverted the outcome to afford linear-selective allylic amination of alkenes. 
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 We looked to these previous successes of our group’s and others to provide new 
reactivity for the Rh-π-allyl complex 4-4. 
 
4.3 Envisioned 3-component Reaction 
 Naturally, the idea we gravitated towards was subjecting a dioxazolone to the 
conditions established for the synthesis of 4-4. We would expect to see a number of 
regioisomers, with 4-6, the branched-selective terminal alkene, dominating (drawn 
below).  
 
Figure 4.8 Proposed Rh(III)-catalyzed 3-component 1,1-carboamination of N-enoxyphthalimides. 
 From a mechanistic standpoint, what we envisioned was a merger between the 
cyclopropanation chemistry and the allylic amination chemistry. We believe the 
formation of intermediate III is the same as previously described. At this point, insertion 
of 4-2 would afford Rhodacycle IV and most likely undergo beta-hydride elimination that 
gives a Rh-hydride diene complex. Intermediate V then affords π-allyl complex VI with 
dioxazolone bound. After oxidation, Rh-nitrene, intermediate VII, undergoes facile 
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4.4 Attempts at 3-component 1,1-Carboamination 
 Initially, we subjected 4-1a under ethylene atmosphere to 4-5a in the presence of 
Ag salt and Rh(III) catalysts. While none of the entries discussed provide the desired 
carboamination product, the consumption of 4-1a was measured in each case in hopes 
of pushing the reactivity forward. With Cp* and Cp*CF3 and catalytic amounts of base, 4-
1a remains untouched. However, when stoichiometric amount of base are used as in 
Figure 4.2, degradation of 4-1a is observed. Furthermore, removing the Ag additive 
causes almost complete consumption of 4-1a with either precatalyst.   
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 Next, we briefly screened other nitrenoid precursors. However, seeing no 
amination products we chose to push forward using dioxazolones as we thought these 
could be an easier oxidation than others we tried.  
 
 
Scheme 4.2 Screen of nitrenoid precursors. 
 Facing a collection of results that showed catalysis was certainly not happening, 
we turned to stoichiometric studies to provide some answers.  
 
4.5 Stoichiometric Studies 
 Typically, when prospecting for new reactivity in the realm of Rh(III)-catalyzed 
C–H functionalization, we begin using the parent Cp* ligand. While consumption of 4-
1a is observed under both Rh(III) precatalysts, π-allyl complex formation is not observed 
with [Cp*RhCl2]2 as the precatalyst. This result indicates that Cp* is not the correct 
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Figure 4.10 Attempted π-allyl complex synthesis with Cp* as a ligand. 
 Additionally, 4-4 was subjected to 4-5a in the presence of KOPiv in TFE at room 
temperature where neither branched nor linear products are observed. This tells us that 
the reaction conditions optimal for the synthesis of 4-4 are not conducive to allylic C–N 
bond formation events. Furthermore, subjecting 4-4 to 4-5a in the presence of 2 
equivalents of a Ag salt in DCE at 40 °C–reaction conditions similar to the allylic 
amination in Figure 4.7–similarly results in no desired product observation. This further 
demonstrates that catalyst selection is even more important. While Cp*CF3 enables 
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Figure 4.11 Attempts at C–N bond formation from π-allyl precursors. 
 From these stoichiometric studies, clearly π-allyl complex 4-4 does not provide 
the desired amination reaction as other unactivated alkenes provide. As of now, we 
believe it due predominately to electronics of the catalyst. From a follow-up report on 
allylic amination of nearly identical C–H bonds, the amination occurs at the more 
electron-rich carbon. The electron-deficient substituent resulting from employing 4-1 as 
starting material imparts a large electronic effect on the substrate. Furthermore, the Cp 
ligand probably needs to be electron deficient to afford the Rh-π-allyl complex. However, 
we believe that for Rh(III) species to undergo 2e-  oxidation, the metal center would 
prefer to be as electron-rich as possible. This step should favor electron-rich Cp ligands, 
as demonstrated in Ir chemistry. This means that these potential 2 key steps lay at odds 
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Figure 4.12 Potential catalyst incompatibility of key steps involved in 1,1-carboamination. 
 
4.6 Summary 
 We have demonstrated that N-enoxyphthalimides, in the presence of 
[Cp*CF3RhCl2]2 complex under ethylene atmosphere, undergo efficient synthesis of a Rh-
π-allyl complex. Based on previous success centered around the design of π-allyl 
intermediates, we envisioned the construction of C–N bond would occur when subjected 
to a nitrenoid precursor. Attempts to catalyze a 1,1-carboamination reaction were made 
with a variety of conditions in the presence of different Rh precatalysts. From 
stoichiometric studies, we can conclude that the choice of catalyst is of utmost priority 



























A) Formation of π-allyl species: Likely favored by electron-deficient Cp
B) Formation of metal nitrene: Likely favored by electron-rich Cp
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– Chapter Five – 
Rh(III)-catalyzed 1,2-Carboamination of Alkenes via sp3 C–H Activation 
 
	
5.1 Introduction to 1,2-Carboamination 
 In 2015, our group reported that under Rh(III) catalysis, 1,2-disubtituted alkenes 
undergo syn-1,2-carboamination using N-enoxyphthalimides.1 Notably, the phthalimide 
handle is incorporated in the product acting as a traceless directing group for C–H 
activation as well as an internal oxidant, making this an incredibly efficient process. This 
is achieved by modifying the Cp ligand on Rh and using methanol as solvent, where N-
enoxyphthalimides–previously known to facilitate cyclopropanation chemistry–
experience a chemoselective transformation. 
 
Figure 5.1 Rh(III)-catalyzed syn-1,2-carboamination of fumarate-type alkenes. 
Mechanistically, methanol is proposed to open the phthalimide ring revealing a 
bidentate directing group. After C–H activation, fumarate type alkenes undergo 
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is proposed via a reductive pathway that yields a Rh(I) complex that is turned over by 
oxidative addition of the N–O bond. Alternatively, C–N bond formation could occur 
through an oxidative pathway via nitrene formation followed by reductive elimination. 
Removal of methanol and heating in toluene results in phthalimide ring closure to 
furnish the desired carboamination product. 
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 Notably, this reaction has recently been rendered enatioselective by Cramer and 
coworker using N-enoxysuccinimides.2 1,2-carboamination of electron-rich alkenes 
using N-enoxyphthalimides has also been reported under photoredox catalysis.3 
 
5.2 Substrates Beyond N-enoxyphthalimides 
 While N-enoxyphthalimides constitute valuable starting materials for the 
construction of C–C and C–N bonds, they come with a large downside of heavy pre-
functionalization. Anderson and coworkers first reported their synthesis over 4 steps 
from styrenes.4 Recently, Cramer and coworker disclosed a concise 1-step alternative to 
the synthesis of N-enoxyimides from terminal alkynes under Au catalysis.5 Importantly, 
this pathway included the ability to produce alkyl substituted N-enoxyimides.  
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Figure 5.3 N-enoxyphthalimide synthesis and potential alternatives. 
 As we began to ponder alternatives to N-enoxyphthalimides, three factors need to 
be considered. Alternatives must have: 1) a nitrogen directing group, 2) a nitrogen-
heteroatom bond as an internal oxidant, and 3) simple starting materials and easy 
synthetic routes. Two candidates emerged as viable starting points: N-acetoxyamines, 
that come from esterification of carboxylic acids, and N-iminoamines, that are the 
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- N–N bond internal oxidant: N-iminoamines
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H
H
	 - 77 - 
5.3 Envisioned Mechanism from N-acetoxyamines 
 Beginning our studies around N-acetoxyamine 5-1, we believe under Rh(III)-
catalysis the nitrogen could direct the Rh to activate the sp3 C–H bond alpha to the 
carbonyl, also taking advantage of the lowered pKa of the bond. If C–H bond activation 
occurs, rhodacycle II may insert an alkene 5-2 that gives 7-membered rhodacycle III. As 
proposed previously, the C–N bond may be furnished via an oxidative or reductive 
mechanism, where both pathways meet at intermediate V. Protodemetallation would 
then turn over the catalyst and give desired carboxylic acid 5-3. 
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5.4 Carboamination of Alkenes from N-acetoxyphthalimides 
 We began our studies using N-acetoxyphthalimide 5-1a with alkene 5-2a in the 
presence of Cp*Rh(III)-precatalyst, KOAc in methanol at varying temperatures. We were 
pleased to find MeOH is capable of phthalimide ring opening in each case. At the time, 
we believed we were seeing the formation of 5-3aa in 14% yield (entries A-C). Buffering 
the system with 1 equiv. of acetic acid caused the yield to decrease to 7% (entry D). 
Varying base between catalytic (0.2 equiv.) and super-stoichiometric (2.5 equiv.) also 
show slight depression in yield of 5-3aa (entries E and F). 
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 After a brief solvent screen, we were surprised to see that TFE was also leading 
to small amounts of 5-3aa (entry G) while other solvents were incapable of activating 5-
1a for functionalization (entries H-J). Similar to the cyclopropanation reaction 
conditions, super-stoichiometric amounts of KOAc showed an increase in yield to 18% 
(entry K). Furthermore, Ag salt additive to render cationic Rh-species saw 5-3aa rise to 
24% yield.  
 
Scheme 5.2 Solvent screen leading to TFE conditions.  
 At this moment in optimizations, we judged the formation of 5-3aa on a doublet 
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attempted isolation of the acid, we found the formation of 5-4aa in its place. While this 
is a carboamination, it is selective for the sp2 C–H functionalization over the desired sp3 
C–H bond functionalization. 
 
 
Figure 5.5 Diagnostic 1H-NMR signal and isolation of undesired byproduct.  
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5.5 Future Considerations Concerning sp3 C–H Functionalization of N-
acetoxyphthalimides 
 
 We believe the phthalimide ring is being opened by alcoholic solvent and 
coordinating the Rh-catalyst with acetate ligand bound. From here, the catalyst 
discriminates between activating sp2 or sp3 C–H bonds. We believe that activation of the 
sp2 C–h bond, while possessing a higher pKa, supplies a more stable rhodacycle. 
Concerning future studies, selection of a Cp ligand may be crucial in order to provide the 
desired sp3 C–H functionalized products.  
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 5.6 Activation of N-iminophthalimides 
 We next shifted our focus on the functionalization of N-iminoamines. Similar to 
5-1a, 5-5a was subjected to alkene 5-2a in the presence of a Cp*Rh(III)-precatalyst with 
base and methanol at reflux. We predicted that using the N–N bond as an internal 
oxidant could result in competing nitrogen sources for C–N bond formation. If the imine 
nitrogen is functionalized, cyclic carboamination would predominate, as opposed to 
acyclic carboamination by functionalization of the phthalimide nitrogen. Unfortunately, 
we did not see any desired product formation, but complete consumption of 5-5a. 
 
Figure 5.7 Attempted carboamination of alkenes with N-iminophthalimides. 
 Because 5-5a was fully consumed, we decided to investigate the initial C–H 
activation using stoichiometric amounts of group 9 [Cp*MCl2]2 complexes. Begininng 
with cobalt, no desired metallacycle was observed for most likely 1 of 2 reasons–either 
it does not provide the desired C–H activation, or it does activate the C–H bond but is 
too unstable to isolate. Using rhodium, metallacycle 5-8ab is formed in 73% yield. 
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Figure 5.8 Isolation of metallacycles. 
 
5.7 Future Directions for sp3 C–H Activation N-iminophthalimides  
 With C–H activation experiments giving positive results, we now look to the 
future toward making this reactivity catalytic. Yu and coworkers recently reported using 
Boc-hydrazones in combination with internal alkynes under Rh(III)-catalysis the 
synthesis of 2,3,5-substituted pyrroles.6 Importantly, the addition of AcOH provides a 
tautomerization from imine to enamine that sets up an sp2 C–H activation. After 
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is formed by reductive elimination. Cleavage of the N–N bond after protonation turns 
over the catalyst.  
 
Figure 5.9 Rh(III)-catalyzed pyrrole synthesis from Boc-hydrazones and alkynes. 
 While this clearly provides a concise synthesis of substituted pyrroles, forcing 
conditions are still required. Potentially, the desired carboamination products could be 
observed with the addition of acid to our systems. Furthermore, other metals could 
provide a forward pathway for alkenes to render saturated N-heterocycles. 
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5.8 Summary 
 Building on previous 1,2 carboamination success using N-enoxypthalimides, we 
investigated two viable alternatives that simplify pre-functionalization and take on the 
additional challenge of activating sp3 C–H bonds. Using N-acetoxyphthlimides, sp2 C–H 
bond activation predominates despite higher activation barriers. Alternative 
investigations with directing groups without competing sp2 C–H bonds are underway. 
Finally, N-iminophthalimides show productive pathways toward sp3 C–H bond 
activation. Isolation of Rh and Ir metallacycles show potential in furnishing new C–X 
bonds. Currently, stoichiometric studies are underway in an effort to push these 
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– Appendix A – 
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Rh(III)-Catalyzed Cyclopropanation of 
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A1.1 General Methods 
 
All reactions were carried out in oven-dried glassware with magnetic stirring. ACS grade 
TFE and reagents were purchased from TCI, Strem, Alfa Aesar, and Sigma-Aldrich and 
were used without further purification. Dichloromethane, tetrahydrofuran, diethyl ether 
were degassed with argon and passed through two columns of neutral alumina. Column 
chromatography was performed on SiliCycle® SilicaFlash® P60, 40-63 µm 60 Å and in 
general were run using flash techniques.11 Thin layer chromatography was performed 
on SiliCycle® 250 µm 60 Å plates. Visualization was accomplished with UV light (254 
nm). 1H, 19F, and 13C NMR spectra were collected at ambient temperature in CDCl3 on 
Bruker 300 MHz, 400 MHz, or 500 MHz spectrometers. Chemical shifts are expressed 
as parts per million (δ, ppm) and are referenced to the residual solvent peak of 
chloroform (1H = 7.26 ppm; 13C = 77.2 ppm). Scalar coupling constants (J) are quoted 
in Hz. Multiplicity is reported as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, m= multiplet). Mass spectra were obtained on a Waters Acquity PDA UPLC/MS 
(LRMS). Infrared (IR) spectra were obtained with neat samples on a Bruker Tensor 27 
FT-IR spectrometer with OPUS software. Typically, the experiment consisted measuring 
the transmission in 8 scans in the region from 4000 to 400 cm-1. 
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A1.2 Synthesis of Starting Materials 
Synthesis of [Cp*CF3RhCl2]2 Catalyst2, 3 
 
Synthesis of 1,2,3,4-tetramethyl-5-(trifluoromethyl)cyclopenta-1,3-diene (+ isomers) 
Figure 1. 
This procedure was performed according to literature precedent. 
 
Synthesis of [Cp*CF3RhCl2]2  
Figure 2. 
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Synthesis of N-enoxyphthalimides 
 
Method A4 (1a-1i) 
 
Figure 3. 
This procedure was performed according to literature precedent. 
 
 
Method B5 (1j) 
 
Figure 4. 
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N-enoxyphthalimide (0.1 mmol), catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.005 mmol, 3.7 mg), 
and CsOAc (2 equiv., 0.2 mmol, 38.5 mg) were weighed in a 1-dram vial with a magnetic 
stirbar. TFE (0.2 M, 500 µL) was added followed by alkene (1.2 equiv., 0.12 mmol). The 
vial was sealed with a screw-cap and stirred at room temperature for 12 hours. Upon 
completion judged by TLC, the crude solution was diluted with EtOAc and partitioned 
with the addition of DI water. The aqueous layer was extracted three times with EtOAc 
and the combined organic extracts were filtered through a pad of celite® and Na2SO4 then 
concentrated. The crude residue was purified by flash chromatography (Hexane:EtOAc, 
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We first examined carboxylate bases beginning with the standard conditions from 
reference 3 using 2-methylenhexane to afford the two diastereomers of cyclopropane 
product. When KOAc proved to be the best we moved on to testing different alkali metal 
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Additionally, we surveyed different alkenes as potential coupling partners. From our 
previous optimization screen, we observed asymmetric 1,1-disubstituted olefins are not 
selective for one diastereomer but the yield drastically drops when the steric load is 
increased from 2-methylenhexane to 2,3-dimethylbut-1-ene. Using 1-decene, we 
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unselective. Finally, we considered symmetrical 1,1-disubstituted alkenes where we 
observed methylencyclohexane gives 99% yield. While these products do not provide 
access to a single diastereomer, we considered this method could improve the synthesis 
of interesting spirocyclic species that can be difficult to access. 
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Characterization of Products 
3aa (2,2-diethylcyclopropyl)(phenyl)methanone 
 
Yield = 40% Colorless oil. Rf = 0.74 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 7.99 (dt, J = 7.2, 1.3 Hz, 2H), 7.59 – 7.51 (m, 1H), 
7.46 (t, J = 7.7 Hz, 2H), 2.51 (dd, J = 7.4, 5.6 Hz, 1H), 1.72 (dq, J = 14.7, 7.4 Hz, 1H), 
1.56 – 1.37 (m, 4H), 1.02 (t, J = 7.4 Hz, 3H), 0.96 (dd, J = 7.5, 4.0 Hz, 1H), 0.77 (t, J = 
7.4 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 198.7, 139.2, 132.5, 128.6, 128.2, 38.3, 32.1, 29.6, 21.3, 
21.1, 11.3, 10.8. 
IR(neat): 2963, 2930, 1666, 1448, 1396, 1215, 1024, 982, 712, 689 cm-1 
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3ab 1-benzoylspiro[2.3]hexane-5,5-dicarbonitrile 
 
Yield = 56% Colorless oil. Rf = 0.39 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 7.98 (dt, J = 8.5, 1.5 Hz, 2H), 7.60 (td, J = 7.3, 
1.5 Hz, 1H), 7.50 (td, J = 7.7, 1.6 Hz, 2H), 3.15 (dtdd, J = 9.6, 8.1, 6.6, 1.6 Hz, 1H), 
2.76 (ddd, J = 7.6, 5.6, 1.4 Hz, 1H), 2.69 (qd, J = 6.8, 5.8, 1.5 Hz, 2H), 2.54 (ddd, J = 
13.0, 9.5, 1.5 Hz, 1H), 1.61 (td, J = 5.3, 1.5 Hz, 1H), 1.33 (ddd, J = 8.4, 4.8, 1.5 Hz, 
1H). 
13C NMR (126 MHz, CDCl3) δ 197.6, 138.2, 133.3, 128.9, 128.1, 122.6, 35.2, 32.2, 31.5, 
29.1, 22.3, 18.1. 
IR(neat): 2992, 2942, 2236, 1661, 1449, 1390, 1335, 1230, 1012, 715, 689 cm-1 
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3ac phenyl(spiro[2.4]heptan-1-yl)methanone 
 
Yield = 87% Colorless oil. Rf = 0.78 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 8.02 – 7.90 (m, 2H), 7.59 – 7.51 (m, 1H), 7.51 – 
7.42 (m, 2H), 2.69 (dd, J = 7.6, 5.5 Hz, 1H), 1.89 – 1.80 (m, 1H), 1.79 – 1.50 (m, 8H), 
1.19 (dd, J = 7.7, 3.9 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 199.1, 139.1, 132.6, 128.6, 128.0, 38.8, 37.5, 32.6, 30.0, 
26.3, 26.2, 22.1. 
IR(neat): 2952, 2864, 1665, 1448, 1390, 1216, 1012, 715, 691 cm-1 













	 - 100 - 
3ad phenyl(spiro[2.5]octan-1-yl)methanone 
 
Yield = 98% Colorless oil. Rf = 0.73 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 8.06 – 7.97 (m, 2H), 7.59 – 7.51 (m, 1H), 7.51 – 
7.43 (m, 2H), 2.51 (dd, J = 7.3, 5.4 Hz, 1H), 1.70 – 1.39 (m, 10H), 1.19 (dt, J = 12.6, 
6.1 Hz, 1H), 0.95 (dd, J = 7.4, 4.0 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 198.4, 139.1, 132.5, 128.6, 128.2, 38.0, 35.6, 32.2, 28.48, 
26.3, 26.2, 26.0, 21.5. 
IR(neat): 2921, 2850, 1664, 1447, 1396, 1216, 980, 718, 689 cm-1 








	 - 101 - 
3ae phenyl(spiro[2.6]nonan-1-yl)methanone 
 
Yield = 70% Colorless oil. Rf = 0.74 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 8.07 – 7.97 (m, 2H), 7.60 – 7.52 (m, 1H), 7.47 
(dd, J = 8.3, 6.9 Hz, 2H), 2.54 (dd, J = 7.5, 5.7 Hz, 1H), 1.80 – 1.66 (m, 4H), 1.58 (tdd, 
J = 14.0, 5.9, 3.9 Hz, 6H), 1.49 (ddt, J = 10.9, 7.4, 5.5 Hz, 2H), 1.32 (dddd, J = 15.9, 
9.5, 7.4, 3.6 Hz, 1H), 0.99 (dd, J = 7.5, 3.9 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 198.7, 139.2, 132.6, 128.6, 128.2, 40.8, 37.1, 33.5, 30.53, 
28.2, 28.1, 26.6, 26.5, 23.3. 
IR(neat): 2920, 2852, 1665, 1448, 1395, 1217, 981, 710, 689 cm-1 












	 - 102 - 
3af phenyl(spiro[2.7]decan-1-yl)methanone 
 
Yield = 53% Colorless oil. Rf = 0.69 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 8.04 – 7.92 (m, 2H), 7.58 – 7.52 (m, 1H), 7.47 
(dd, J = 8.4, 6.9 Hz, 2H), 2.50 (dd, J = 7.5, 5.7 Hz, 1H), 1.92 (ddd, J = 14.4, 8.7, 2.8 
Hz, 1H), 1.82 – 1.56 (m, 10H), 1.55 – 1.38 (m, 4H), 1.00 (dd, J = 7.5, 4.0 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 198.7, 139.3, 132.6, 128.6, 128.2, 39.1, 36.6, 34.6, 27.9, 
27.4, 26.9, 25.9, 25.6, 25.3, 23.3. 
IR(neat): 2944, 2911, 1668, 1472, 1447, 1216, 1010, 945, 734, 702 cm-1 








	 - 103 - 
3ag phenyl(6-tosyl-6-azaspiro[2.5]octan-1-yl)methanone 
 
Yield = 72% White solid. Rf = 0.22 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 7.82 (dd, J = 8.3, 1.4 Hz, 2H), 7.61 – 7.56 (m, 
2H), 7.54 – 7.49 (m, 1H), 7.40 – 7.33 (m, 2H), 7.27 – 7.24 (m, 2H), 3.14 (qdd, J = 11.4, 
7.0, 4.6 Hz, 2H), 2.94 (ddd, J = 11.3, 7.2, 3.8 Hz, 1H), 2.76 (ddd, J = 11.7, 7.3, 3.7 Hz, 
1H), 2.50 (dd, J = 7.6, 5.5 Hz, 1H), 2.42 (s, 3H), 1.73 (dtdd, J = 21.2, 17.2, 13.1, 8.8 
Hz, 4H), 1.51 (dd, J = 5.4, 4.5 Hz, 1H), 0.95 (dd, J = 7.6, 4.4 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 197.5, 143.6, 138.5, 133.0, 132.8, 129.7, 128.7, 128.0, 
127.8, 46.5, 46.1, 36.1, 31.7, 30.6, 27.5, 21.7, 20.3. 
IR(neat): 2972, 2819, 1666, 1602, 1451, 1373, 1239, 1170, 890, 711, 688 cm-1 












	 - 104 - 
3ah tert-butyl 1-benzoyl-6-azaspiro[2.5]octane-6-carboxylate 
 
Yield = 84% Colorless oil. Rf = 0.45 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 8.02 – 7.96 (m, 2H), 7.60 – 7.53 (m, 1H), 7.47 
(dd, J = 8.3, 6.9 Hz, 2H), 3.61 – 3.49 (m, 2H), 3.37 (ddd, J = 13.1, 6.6, 4.2 Hz, 1H), 
3.13 (ddd, J = 13.2, 7.0, 4.3 Hz, 1H), 2.62 (dd, J = 7.5, 5.4 Hz, 1H), 1.64 – 1.57 (m, 4H), 
1.43 (s, 9H), 1.05 (dd, J = 7.5, 4.2 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 197.8, 155.0, 138.7, 134.5, 132.9, 128.8, 128.2, 123.8, 
79.7, 77.4, 36.8, 33.0, 30.9, 28.6, 20.6. 
IR(neat): 2975, 2818, 1666, 1419, 1365, 1238, 1166, 1120, 903, 720, 689 cm-1 









	 - 105 - 
3ai phenyl(6-phenylspiro[2.5]octan-1-yl)methanone 
 
Yield = 97% White solid. Rf = 0.58 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 8.02 – 7.94 (m, 2H), 7.61 – 7.54 (m, 1H), 7.53 – 
7.46 (m, 2H), 7.34 – 7.28 (m, 2H), 7.27 – 7.23 (m, 2H), 7.23 – 7.17 (m, 1H), 2.58 (dq, 
J = 8.5, 5.6, 4.6 Hz, 2H), 2.25 (tdd, J = 12.9, 3.8, 1.7 Hz, 1H), 1.94 (ddt, J = 21.9, 12.7, 
2.7 Hz, 2H), 1.77 – 1.56 (m, 4H), 1.48 (tdd, J = 12.9, 3.7, 1.5 Hz, 1H), 1.31 (dq, J = 
13.0, 3.0 Hz, 1H), 0.99 (ddd, J = 7.4, 4.0, 1.6 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 198.2, 147.1, 139.1, 132.7, 128.7, 128.6, 128.2, 127.0, 
126.2, 44.4, 40.3, 37.7, 33.6, 33.5, 32.4, 29.0, 20.4. 
IR(neat): 2921, 2872, 1671, 1492, 1277, 1216, 970, 755, 698 cm-1 












	 - 106 - 
3bd spiro[2.5]octan-1-yl(p-tolyl)methanone 
 
Yield = 97% Colorless oil. Rf = 0.81 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 7.92 (d, J = 8.2 Hz, 2H), 7.26 (d, J = 7.9 Hz, 2H), 
2.49 (dd, J = 7.3, 5.4 Hz, 1H), 2.42 (s, 3H), 1.73 – 1.54 (m, 4H), 1.47 (dddd, J = 28.0, 
16.4, 9.6, 4.9 Hz, 6H), 1.17 (dt, J = 12.4, 6.1 Hz, 1H), 0.92 (dd, J = 7.3, 4.0 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 197.9, 143.2, 136.7, 129.3, 128.3, 38.0, 35.2, 32.1, 28.5, 
26.4, 26.2, 26.0, 21.8, 21.2. 
IR(neat): 2923, 2854, 1663, 1410, 1217, 1155, 854, 806, 598 cm-1 








	 - 107 - 
3cd (4-(tert-butyl)phenyl)(spiro[2.5]octan-1-yl)methanone 
 
Yield = 89% Colorless oil. Rf = 0.75 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 7.99 – 7.93 (m, 2H), 7.51 – 7.44 (m, 2H), 2.49 
(dd, J = 7.4, 5.4 Hz, 1H), 1.70 – 1.39 (m, 10H), 1.35 (s, 9H), 1.21 (dd, J = 11.2, 5.8 Hz, 
1H), 0.92 (dd, J = 7.4, 4.0 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 198.0, 156.1, 136.6, 128.2, 125.6, 38.0, 35.2, 32.1, 31.3, 
28.5, 26.4, 26.2, 26.1, 21.2. 
IR(neat): 2903, 2868, 1662, 1409, 1223, 854, 808, 598 cm-1 












	 - 108 - 
3dd (4-fluorophenyl)(spiro[2.5]octan-1-yl)methanone 
 
Yield = 96% Colorless oil. Rf = 0.75 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 8.08 – 7.99 (m, 2H), 7.19 – 7.10 (m, 2H), 2.45 
(dd, J = 7.4, 5.4 Hz, 1H), 1.69 – 1.56 (m, 4H), 1.54 – 1.41 (m, 6H), 1.15 (d, J = 15.6 
Hz, 1H), 0.95 (dd, J = 7.3, 4.0 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 196.7, 165.5 (d, J = 253.8 Hz), 135.5 (d, J = 3.0 Hz), 
130.7 (d, J = 9.1 Hz), 115.7 (d, J = 21.6 Hz), 38.0, 35.7, 32.1, 28.5, 26.3, 26.2, 26.0, 
21.5. 
IR(neat): 2929, 2854, 1665, 1506, 1216, 1155, 854, 710, 598 cm-1 








	 - 109 - 
3ed spiro[2.5]octan-1-yl(m-tolyl)methanone 
 
Yield = 75% Colorless oil. Rf = 0.84 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 7.84 – 7.79 (m, 2H), 7.36 (m, 1H), 7.35 (m, 1H), 
2.50 (dd, J = 7.4, 5.5 Hz, 1H), 2.42 (s, 3H), 1.70 – 1.40 (m, 10H), 1.20 (dt, J = 12.1, 6.0 
Hz, 1H), 0.93 (dd, J = 7.3, 4.0 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 198.5, 139.2, 138.4, 133.3, 128.7, 128.5, 125.5, 38.0, 
35.5, 32.2, 28.5, 26.3, 26.2, 26.0, 21.6, 21.5. 
IR(neat): 2922, 2857, 1664, 1240, 1180, 755, 688 cm-1 












	 - 110 - 
3fd (3-methoxyphenyl)(spiro[2.5]octan-1-yl)methanone 
 
Yield = 67% Colorless oil. Rf = 0.72 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 7.62 (dd, J = 7.7, 1.5 Hz, 1H), 7.52 (t, J = 2.0 Hz, 
1H), 7.37 (t, J = 7.9 Hz, 1H), 7.09 (dd, J = 8.2, 2.6 Hz, 1H), 3.86 (s, 3H), 2.49 (dd, J = 
7.3, 5.5 Hz, 1H), 1.70 – 1.40 (m, 8H), 1.19 (m, 1H), 0.94 (dd, J = 7.3, 4.0 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 198.1, 159.9, 140.5, 129.6, 120.9, 118.9, 112.5, 55.6, 
38.0, 35.7, 32.3, 28.5, 26.3, 26.1, 26.0, 21.6. 
IR(neat): 2921, 2850, 1664, 1595, 1448, 1284, 1259, 1034, 870, 845, 762, 684 cm-1 








	 - 111 - 
3gd (3-fluorophenyl)(spiro[2.5]octan-1-yl)methanone 
 
Yield = 90% Colorless oil. Rf = 0.75 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 7.80 (dt, J = 7.8, 1.3 Hz, 1H), 7.67 (ddd, J = 9.6, 
2.7, 1.6 Hz, 1H), 7.44 (td, J = 8.0, 5.5 Hz, 1H), 7.28 – 7.20 (m, 1H), 2.45 (dd, J = 7.4, 
5.4 Hz, 1H), 1.70 – 1.39 (m, 10H), 1.17 (d, J = 9.8 Hz, 1H), 0.98 (dd, J = 7.3, 4.0 Hz, 
1H). 
13C NMR (126 MHz, CDCl3) δ 197.0 (d, J = 2.1 Hz), 163.0 (d, J = 247.5 Hz), 141.2 (d, 
J = 6.2 Hz), 130.3 (d, J = 7.7 Hz), 123.9 (d, J = 3.2 Hz), 119.5 (d, J = 21.6 Hz), 115.0 
(d, J = 22.2 Hz), 38.0, 36.2, 32.3, 28.4, 26.3, 26.2, 26.1, 21.9. 
IR(neat): 2929, 2854, 1667, 1511, 1410, 1214, 1111, 830, 757 cm-1 










	 - 112 - 
3hd (2-fluorophenyl)(spiro[2.5]octan-1-yl)methanone 
 
Yield = 59% Colorless oil. Rf = 0.75 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 7.76 (td, J = 7.6, 1.9 Hz, 1H), 7.48 (tdd, J = 7.2, 
4.9, 1.9 Hz, 1H), 7.21 (t, J = 7.5 Hz, 1H), 7.13 (dd, J = 10.9, 8.4 Hz, 1H), 2.48 (ddd, J 
= 7.2, 5.5, 3.4 Hz, 1H), 1.54 (ddtd, J = 33.0, 28.4, 11.4, 10.3, 5.2 Hz, 10H), 1.32 – 1.21 
(m, 1H), 0.95 (dd, J = 7.3, 3.9 Hz, 1H). 
13C NMR (126 MHz, Chloroform-d) δ 197.0 (d, J = 3.2 Hz), 161.6 (d, J = 253.5 Hz), 
133.8 (d, J = 8.7 Hz), 130.5 (d, J = 2.7 Hz), 128.3 (d, J = 13.1 Hz), 124.4 (d, J = 3.5 
Hz), 116.7 (d, J = 23.5 Hz), 37.9, 36.9, 36.3, 36.3, 28.4, 26.3, 26.2, 25.8, 25.8, 22.6. 
IR(neat): 2930, 2854, 1672, 1479, 1453, 1346, 1204, 1102, 829, 757 cm-1 








	 - 113 - 
3id naphthalen-2-yl(spiro[2.5]octan-1-yl)methanone 
 
Yield = 67% Colorless oil. Rf = 0.77 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 8.56 (d, J = 1.7 Hz, 1H), 8.08 (dd, J = 8.6, 1.8 Hz, 
1H), 8.04 – 7.96 (m, 1H), 7.90 (dd, J = 10.1, 8.1 Hz, 2H), 7.57 (dddd, J = 18.9, 8.1, 6.8, 
1.4 Hz, 2H), 2.67 (dd, J = 7.4, 5.4 Hz, 1H), 1.57 (tddd, J = 50.6, 21.1, 10.8, 5.2 Hz, 
10H), 1.20 (dq, J = 11.9, 6.1, 5.0 Hz, 1H), 1.00 (dd, J = 7.3, 4.0 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 198.1, 136.5, 135.5, 132.8, 129.7, 129.6, 128.4, 128.3, 
127.9, 126.8, 124.4, 38.1, 35.7, 32.3, 28.6, 26.3, 26.2, 26.1, 21.6. 
IR(neat): 2916, 2846, 1654, 1398, 1183, 1125, 1116, 808, 780 cm-1 











	 - 114 - 
3jd 3-phenyl-1-(spiro[2.5]octan-1-yl)propan-1-one 
 
Yield = 98% Colorless oil. Rf = 0.81 (4:1 hexanes: Ethyl Acetate). 
1H NMR (500 MHz, Chloroform-d) δ 7.31 – 7.26 (m, 2H), 7.24 – 7.17 (m, 3H), 2.96 – 
2.88 (m, 4H), 1.79 (dd, J = 7.4, 5.4 Hz, 1H), 1.58 – 1.38 (m, 9H), 1.28 (dd, J = 5.5, 3.9 
Hz, 1H), 1.13 (p, J = 7.5 Hz, 1H), 0.80 (dd, J = 7.4, 4.0 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 207.7, 141.5, 128.6, 128.5, 126.2, 46.4, 37.9, 35.2, 34.7, 
30.3, 28.1, 26.3, 26.2, 26.1, 22.1. 
IR(neat):  2921, 2850, 1692, 1445, 1398, 1117, 1082, 748, 699 cm-1 
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N-enoxyphthalimide 1a (0.1 mmol), catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.005 mmol), and 
CsOAc (2 equiv., 0.2 mmol) were weighed in a 1-dram vial with a magnetic stirbar. TFE-
d1 (0.2 M, 500 µL) was added. The vial was sealed with a screw-cap and stirred for 3 
hours. Upon completion judged by TLC, the crude solution was diluted with EtOAc and 
partitioned with the addition of DI water. The aqueous layer was extracted three times 
with EtOAc and the combined organic extracts were filtered through a pad of celite® and 
Na2SO4 then concentrated. The crude residue was purified by flash chromatography 

















N-enoxyphthalimide 1a (0.1 mmol), catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.005 mmol), and 
CsOAc (2 equiv., 0.2 mmol) were weighed in a 1-dram vial with a magnetic stirbar. TFE 
(0.2 M, 500 µL) was added followed by addition of alkene 2d (1.2 equiv. 0.12 mmol). 
The vial was sealed with a screw-cap and stirred for 3 hours. Upon completion judged 
by TLC, the crude solution was diluted with EtOAc and partitioned with the addition of 
DI water. The aqueous layer was extracted three times with EtOAc and the combined 
organic extracts were filtered through a pad of celite® and Na2SO4 then concentrated. 






















N-enoxyphthalimide 1a (0.1 mmol) and CsOAc (2 equiv., 0.2 mmol, 38.5 mg) were 
weighed in a 1-dram vial with a magnetic stirbar. TFE (0.2 M, 500 µL) was added and 
the vial was sealed with a screw-cap and stirred at room temperature for 12 hours. Upon 
completion judged by TLC, the crude solution was diluted with EtOAc and partitioned 
with the addition of DI water. The aqueous layer was extracted three times with EtOAc 
and the combined organic extracts were filtered through a pad of celite® and Na2SO4 then 
concentrated. The crude residue was purified by flash chromatography (Hexane:EtOAc, 
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4 2,2,2-trifluoroethyl 2-(5-methyl-5-phenyl-1,4,2-dioxazol-3-yl)benzoate 
 
Yield = 59% Colorless oil. Rf = 0.60 (4:1 Hexanes: Ethyl Acetate) 
1H NMR (500 MHz, Chloroform-d) δ 7.85 – 7.77 (m, 1H), 7.77 – 7.70 (m, 1H), 7.66 – 
7.55 (m, 4H), 7.49 – 7.36 (m, 3H), 4.63 (dq, J = 12.6, 8.4 Hz, 1H), 4.49 (dq, J = 12.6, 
8.4 Hz, 1H), 2.02 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 165.36, 157.63, 139.94, 132.19, 131.42, 130.27, 130.15, 
129.84, 129.42, 128.63, 125.19, 123.14, 116.33, 61.34 (q, J = 36.9 Hz), 25.52. 
IR(neat): 2975, 1746, 1494, 1292, 1163, 1123, 1097, 1010, 963, 698, 581 cm-1 















	 - 119 - 
 
Figure 10. 
Dioxazoline 4 (0.1 mmol), catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.005 mmol), and CsOAc 
(2 equiv., 0.2 mmol) were weighed in a 1-dram vial with a magnetic stirbar. TFE (0.2 M, 
500 µL) was added followed by addition of alkene 2d (1.2 equiv. 0.12 mmol). The vial 
was sealed with a screw-cap and stirred for 3 hours. Upon completion judged by TLC, 
the crude solution was diluted with EtOAc and partitioned with the addition of DI water. 
The aqueous layer was extracted three times with EtOAc and the combined organic 
extracts were filtered through a pad of celite® and Na2SO4 then concentrated. The yield 

























Based on the experiment in figure 10, we conclude that the dioxazoline 4 does not 
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A1.5 NMR Spectra  
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PERMISSION/LICENSE IS GRANTED FOR YOUR ORDER AT NO CHARGE 
This type of permission/license, instead of the standard Terms & Conditions, is sent to 
you because no fee is being charged for your order. Please note the following: 
 
 
- Permission is granted for your request in both print and electronic formats, and 
translations. 
- If figures and/or tables were requested, they may be adapted or used in part. 
- Please print this page for your records and send a copy of it to your 
publisher/graduate school. 
- Appropriate credit for the requested material should be given as follows: "Reprinted 
(adapted) with permission from (COMPLETE REFERENCE CITATION). Copyright 
(YEAR) American Chemical Society." Insert appropriate information in place of the 
capitalized words. 
- One-time permission is granted only for the use specified in your request. No 
additional uses are granted (such as derivative works or other editions). For any other 
uses, please submit a new request. 
 
If credit is given to another source for the material you requested, permission must be 
obtained from that source. 
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A2.1 General Methods 
 
All reactions were carried out in oven-dried glassware with magnetic stirring. ACS 
grade TFE and reagents were purchased from TCI, Strem, Alfa Aesar, and Sigma-
Aldrich and were used without further purification. Dichloromethane, tetrahydrofuran, 
diethyl ether were degassed with argon and passed through two columns of neutral 
alumina. Column chromatography was performed on SiliCycle® SilicaFlash® P60, 40-
63 µm 60 Å and in general were run using flash techniques.1 Thin layer 
chromatography was performed on SiliCycle® 250 µm 60 Å plates. Visualization was 
accomplished with UV light (254 nm). 1H, 19F, and 13C NMR spectra were collected at 
ambient temperature in CDCl3 on Bruker 300Hz, 400 MHz, or 500MHz spectrometers. 
Chemical shifts are expressed as parts per million (δ, ppm) and are referenced to the 
residual solvent peak of chloroform(1H = 7.26 ppm; 13C = 77.2 ppm). Scalar coupling 
constants (J) are quoted in Hz. Multiplicity is reported as follows: s = singlet, d = 
doublet, t = triplet, q = quartet, m= multiplet). Mass spectra were obtained on a 
Waters (LRMS). Infrared (IR) spectra were obtained with neat samples on a Bruker 
Tensor 27 FT-IR spectrometer with OPUS software. Typically, the experiment 
consisted measuring the transmission in 16 scans in the region from 4000 to 400 cm-1. 
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A2.2 General Procedure for Starting Materials 
 
A. Synthesis of [Cp*CF3RhCl2]2 Catalyst2 
 
Synthesis of 1,2,3,4-tetramethyl-5-(trifluoromethyl)cyclopenta-1,3-diene (+ isomers) 
 
Following a reported procedure, Li wire (1.291 g, 186 mmol, 4 equiv.) was cut into ~5 
mm size pieces and added to Et2O (2.85 M, 69 mL) in a 250-mL 3-neck flask with a 
magnetic stir bar and cooled to 0 ˚C in an ice bath. 2-bromo-2-butene (cis + trans) 
(9.7 mL, 95.3 mmol, 2.05 equiv.) diluted with 10 mL Et2O was added dropwise over 10 
minutes. The heterogeneous mixture was stirred for 2 hours then cooled to -40 ˚C 
(MeCN, Dry Ice bath). Ethyl trifluoroacetate (5.4 mL, 46.5 mmol, 1 equiv.) diluted 
with 5 mL Et2O was added dropwise over 10 minutes. The solution was stirred for an 
additional 90 minutes. The solution was quenched with 20 mL of 2 M HCl solution 
and diluted with 100 mL DI H2O. The solution was transferred to a separatory funnel 
and the layers separated. The aqueous layer was extracted three times with Et2O. The 
organic layers were combined and washed with saturated sodium bicarbonate, water, 
and brine then dried over Na2SO4 and concentrated. The resulting yellow liquid was 
Me Me
Br Li0 wire
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vacuum distilled to give the intermediate alcohol, a clear liquid, in 43% yield (4.1734 
g).  
The intermediate alcohol (1.0 g, 4.8 mmol, 1 equiv.) was dissolved in DCM (0.16 M, 
30 mL) in a 50-mL flask equipped with a magnetic stir bar and cooled to 0 ˚C in an ice 
bath. Methanesulfonic acid (3.1 mL, 48 mmol, 10 equiv.) was quickly added and the 
solution was stirred for 5 minutes. The resulting dark red solution was then poured 
into 50 mL of cooled DI H2O. The solution was transferred to separatory funnel and 
the layers were separated. The aqueous layer was extracted three times with DCM. The 
organic layers were combined and washed with saturated sodium bicarbonate, dried 
over dried over Na2SO4 and concentrated. HCp*CF3 (+ isomers) was purified by flash 
chromatography (Hexanes) and afforded in 69% yield (1.3374 g) 
 
Synthesis of [Cp*CF3RhCl2]2  
 
From a reported procedure, in a 250-mL flask equipped with a magnetic stir bar and a 
reflux condenser under N2 atmosphere was added RhCl3 • 3 H2O (700 mg, 2.6 mmol, 1 
equiv.), MeOH (140 mL, 0.019 M), and HCp*CF3 (1.3374 g, 7.28 mmol, 2.7 equiv.). 
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The solution was refluxed under N2 atmosphere for 3 days where a dark red precipitate 
was visible on the sides of the flask. The reaction was cooled to 0 ˚C in an ice bath and 
the precipitate was filtered and washed with EtOH two additional times. The resulting 
red solid was collected and dried to afford 72% yield (1.33 g). The  
 
B. Synthesis of N-enoxyphthalimide Substrates 
 
Method A3 
Synthesis of (1,2-dibromoethyl)arenes 
 
Styrene (1 equiv.) in DCM (0.5M) was cooled to 0 ˚C and Br2 (1.2 equiv.) was added 
via syringe and stirred at 0 ˚C for ~1 hour. The solution was quenched with sat. 
Na2S2O3 until the solution became colorless. The resulting solutions was then filtered 
through a pad a celite® and washed with DCM. The layers were then separated and the 
aqueous layer was extracted with DCM. The combined organic layers were then 
washed with brine, dried over Na2SO4, and concentrated. The resulting white solid was 








	 - 148 - 
Synthesis of a-bromostyrenes 
 
(1,2-dibromoethyl)arenes (1 equiv.) was stirred in a 0.25M solution of 1:1 methanol 
and THF at room temperature. Potassium carbonate (2 equiv.) was added and the 
solution stirred until the reaction was judged complete by TLC (~3 hrs.). The reaction 
was then quenched with D.I. water and the volatiles were removed. The resulting 
aqueous layer was extracted with ether and the combined organic layers were then 
washed with brine, dried over Na2SO4, and concentrated. 
The resulting oil was directly carried on without purification. 
 
Synthesis of (1-arylvinyl)boronic acids 
 
a-bromostyrene in dry diethyl ether was put under inert atmosphere in a 2-neck flask 
and cooled to -78 ˚C. A 1.7M solution of t-BuLi in pentanes (2.1 equiv.) was added 
dropwise and the solution was stirred at -78 ˚C for 30 minutes. Tri-isopropylborate 
(1.2 equiv.) was added dropwise to the solution over 30 minutes. After the addition 











Et2O, -78 ˚C to rt
R
Br
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was removed from the cold bath and stirred at room temperature overnight. To the 
resulting yellow-orange solution was added 1M HCl solution and was stirred for 2 
hours. The layers were separated and the aqueous layer was extracted with ether. The 
combined organic layers were then washed with 1M NaOH solution and the layers 
were separated. The aqueous layer was acidified to pH≈1 and extracted with ethyl 
acetate. The combined organic layers were then washed with brine, dried over Na2SO4, 
and concentrated. The crude product was directly carried on without purification. 
 
 
Synthesis of N-enoxyphthalimides 
 
Boronic acid (2 equiv.), copper(II) acetate (1 equiv.), N-hydroxyphthalimide (1 equiv.), 
and anhydrous sodium sulfate (4 equiv.) were combined in a flask and diluted with 
1,2-dichloroethane to form a 0.1M solution of N-hydroxyphthalimide. Pyridine (3 
equiv.) was added via syringe and the solution was stirred at room temperature open to 
air for 2 days. At the end of the stirring period, the volatiles were removed and the 
resulting solids were purified by column chromatography. The purified solids were 

















Following a reported procedure, alkyne (3 equiv.), N-hydroxphthalimide (1 equiv.), and 
Au catalyst (5 mol%) were combined in a 1.5 dram vial in the glove box under Ar and 
dissolved in 1,2-DCE (0.2M). The vial was sealed and removed from the glovebox and 
placed in an aluminum heating block overnight at 90 ºC. The reaction was then cooled 
to room temperature, diluted with DCM and passed through a pad of Celite®. The 
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Compounds Synthesized by Method A
Compounds Synthesized by Method B
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C. Synthesis of Allylic Alcohol Substrates and Analogues. 
 
Allylic alcohols were purchased from commercial suppliers unless noted below: 
 
 
This procedure was performed according to literature precedent.5, 6, 7 
 
 
This procedure was performed similar to literature precedent. The crude mixture was 
purified by flash chromatography (9:1®4:1, Hex:EtOAc). The compound was 














R = Cy or PhX = Cl or Br
HO
1) NBS, AIBN
    CCl4
    reflux
2) NaHCO3
    acetone:H2O (2:1)







THF, 0 °C to rt
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This procedure was performed according to literature precedent and the compound was 
consistent with the literature.9 
 
 
This procedure was performed according to literature precedent and the compound was 





This procedure was performed according to the literature precedent and the 
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N-enoxyphthalimide (0.12 mmol), catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.006 mmol, 4.4 
mg), and KOPiv (2 equiv., 0.24 mmol, 33.6 mg) were weighed in a 1-dram vial with a 
magnetic stirbar. Cooled TFE (0.2 M, 600 µL) was added followed by allylic alcohol 
(1.2 equiv., 0.144 mmol). The vial was sealed with a screw-cap and placed in an 
aluminium block cooled to 0 ˚C surrounded by ice in an insulated box and stirred for 
16 hours. Upon completion judged by TLC, TFE was removed by rotary evaporation 
and the residue was taken up in EtOAc and filtered through a silica plug flushing with 
EtOAc. The filtrate was concentrated to ~1mL and transferred to a 1.5-dram vial where 
the solution was partitioned with the addition of 10% NaOH solution. The aqueous 
layer was extracted three times with EtOAc and the combined organic extracts were 
filtered through a pad of celite® and Na2SO4 then concentrated. The crude residue was 




















Y = 81%. Yellow oil. Rf = 0.22 (4:1 Hexanes:EtOAc)  
1H NMR (500 MHz, Chloroform-d) δ 8.05 – 7.94 (m, 2H), 7.56 (t, J = 7.4 Hz, 1H), 
7.47 (t, J = 7.6 Hz, 2H), 3.95 (dd, J = 12.0, 4.7 Hz, 1H), 3.76 (dd, J = 12.0, 8.3 Hz, 
1H), 2.55 (dd, J = 8.4, 5.0 Hz, 1H), 2.14 (s, 1H), 1.89 – 1.81 (m, 1H), 1.78 – 1.71 (m, 
1H), 1.45 (tdd, J = 13.4, 10.7, 4.8 Hz, 4H), 0.93 (t, J = 6.9 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 200.2, 138.6, 133.0, 128.7, 128.2, 60.0, 35.6, 35.4, 30.3, 
28.5, 22.4, 14.0. 
IR(neat) 3456, 2924, 1660, 1453, 1228, 1019, 700 cm-1 
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3ab 2-(hydroxymethyl)-3-propylcyclopropyl)(phenyl)methanone 
 
Y = 62%. Pale-yellow oil. Rf = 0.22 (4:1 Hexanes:EtOAc) 
1H NMR (500 MHz, Chloroform-d) δ 8.03 – 7.95 (m, 2H), 7.61 – 7.54 (m, 1H), 7.46 
(dd, J = 8.4, 7.0 Hz, 2H), 4.06 (dd, J = 7.9, 2.7 Hz, 2H), 2.73 (dd, J = 9.4, 7.9 Hz, 1H), 
2.45 (s, 1H), 1.90 – 1.72 (m, 2H), 1.55 (ddt, J = 13.9, 8.4, 6.9 Hz, 1H), 1.49 – 1.40 (m, 
1H), 1.35 – 1.25 (m, 2H), 0.85 (t, J = 7.4 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 200.7, 138.9, 133.1, 128.7, 128.3, 58.7, 28.0, 28.0, 26.5, 
25.5, 23.1, 14.0. 
IR(neat) 3433, 2957, 1680, 1449, 1209, 1020, 699 cm-1 
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3ba 2-(hydroxymethyl)-3-propylcyclopropyl)(p-tolyl)methanone 
 
Y = 72%. Yellow oil. Rf = 0.22 (4:1 Hexanes:EtOAc) 
1H NMR (500 MHz, Chloroform-d) δ 7.90 (d, J = 8.2 Hz, 2H), 7.27 (d, J = 7.5 Hz, 
2H), 3.94 (dd, J = 12.3, 4.8 Hz, 1H), 3.80 – 3.71 (dd, J = 9.0, 5.8 Hz, 1H), 2.52 (dd, J 
= 8.4, 5.1 Hz, 1H), 2.42 (s, 3H), 2.19 (s, 1H), 1.86 – 1.79 (m, 1H), 1.72 (tdd, J = 8.3, 
6.5, 4.6 Hz, 1H), 1.52 – 1.37 (m, 4H), 0.98 – 0.89 (t, J = 7.0 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 199.8, 143.8, 136.1, 129.4, 128.4, 60.1, 35.5, 35.4, 30.1, 
28.3, 22.4, 21.8, 14.0. 
IR(neat) 3441, 2957, 2923, 1663, 1607, 1454, 1233, 1179, 103, 665 cm-1 
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3ca (4-(tert-butyl)phenyl)-2-(hydroxymethyl)-3-propylcyclopropyl)methanone 
 
Y = 76%. Pale-yellow oil. Rf = 0.24 (4:1, Hexanes:EtOAc). 
1H NMR (500 MHz, Chloroform-d) δ 7.95 (d, J = 8.5 Hz, 1H), 7.49 (d, J = 8.5 Hz, 
2H), 3.98 – 3.91 (m, 1H), 3.81 – 3.72 (m, 1H), 2.54 (dd, J = 8.4, 5.0 Hz, 1H), 2.18 (s, 
1H), 1.87 – 1.80 (m, 1H), 1.73 (tdd, J = 8.3, 6.5, 4.6 Hz, 1H), 1.53 – 1.40 (m, 4H), 
1.35 (s, 9H), 0.93 (t, J=6.9 Hz, 3H). 
13C NMR (126 MHz, CDCl3) 13C NMR (126 MHz, CDCl3) δ 199.9, 156.8, 134.5, 128.2, 
125.7, 123.8, 60.12, 35.5, 35.4, 31.3, 30.2, 28.3, 22.4, 14.0. 
IR(neat) 3210, 2956, 2923, 2852, 1736, 1606, 1234, 1109, 834, 852, 796 cm-1 
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3da (4-fluorophenyl)(2-(hydroxymethyl)-3-propylcyclopropyl)methanone 
 
Y = 69%. Yellow Oil. Rf = 0.16 (4:1 Hexanes:EtOAc).  
1H NMR 1H NMR (500 MHz, Chloroform-d) δ 8.02 (dd, J = 8.5, 5.4 Hz, 2H), 7.13 (t, J 
= 8.5 Hz, 2H), 3.94 (dd, J = 11.9, 4.7 Hz, 1H), 3.72 (dd, J = 12.0, 8.4 Hz, 1H), 2.48 
(dd, J = 8.4, 5.0 Hz, 1H), 2.14 (s, 1H), 1.82 (p, J = 6.2 Hz, 1H), 1.74 (qd, J = 8.3, 5.6 
Hz, 1H), 1.44 (tt, J = 13.9, 7.1 Hz, 4H), 0.92 (t, J = 6.8 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 198.5, 166.8, 164.8, 135.0, 135.0, 130.9, 130.8, 115.9, 
115.7, 60.0, 35.6, 35.4, 30.1, 28.4, 22.4, 14.0. 
19F NMR (282 MHz, Chloroform-d) δ -104.95 (ddd, J = 13.7, 8.5, 5.4 Hz). 
IR(neat) 3458, 2958, 2926, 1667, 1599, 1507, 1229, 1155, 1031, 838 cm-1 
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3ea (2-(hydroxymethyl)-3-propylcyclopropyl)(4-methoxyphenyl)methanone 
 
Y = 77%. Pale-Yellow Oil. Rf = 0.06 (4:1 Hexanes:EtOAc).  
1H NMR (500 MHz, Chloroform-d) δ 7.99 (d, J = 8.8 Hz, 2H), 6.95 (d, J = 8.8 Hz, 
2H), 3.94 (dd, J = 12.0, 4.6 Hz, 1H), 3.87 (s, 3H), 3.75 (dd, J = 12.1, 8.2 Hz, 1H), 2.49 
(dd, J = 8.4, 5.0 Hz, 1H), 2.26 (s, 1H), 1.80 (p, J = 6.3 Hz, 1H), 1.73 – 1.66 (m, 1H), 
1.51 – 1.38 (m, 4H), 0.93 (t, J = 6.9 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 198.7, 131.6, 130.5, 113.9, 60.2, 55.7, 35.5, 35.1, 29.9, 
28.0, 22.4, 14.0. 
IR(neat) 3436, 2957, 2926, 1655, 1600, 1235, 1170, 1026, 845 cm-1  
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3fa (2-(hydroxymethyl)-3-propylcyclopropyl)(m-tolyl)methanone 
 
Y = 52%. Pale-yellow oil. Rf = 0.30 (4:1 Hexanes:EtOAc).  
1H NMR (500 MHz, Chloroform-d) δ 7.80 (q, J = 2.4 Hz, 2H), 7.42 – 7.32 (m, 2H), 
3.94 (dd, J = 12.0, 4.6 Hz, 1H), 3.76 (dd, J = 12.0, 8.3 Hz, 1H), 2.54 (dd, J = 8.4, 5.0 
Hz, 1H), 2.42 (s, 3H), 2.15 (s, 1H), 1.88 – 1.79 (m, 1H), 1.74 (tdd, J = 8.4, 6.5, 4.6 Hz, 
1H), 1.51 – 1.38 (m, 4H), 0.97 – 0.89 (m, 3H). 
13C NMR (126 MHz, CDCl3) δ 200.3, 138.5, 138.4, 133.6, 128.6, 128.4, 125.3, 59.9, 
35.4, 35.3, 30.1, 28.3, 22.2, 21.4, 13.8. 
IR(neat) 3445, 2955, 2870, 1664, 1604, 1163, 1054, 1030, 708 cm-1 
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3ga 2-(hydroxymethyl)-3-propylcyclopropyl)(3-methoxyphenyl)methanone 
 
Y = 93%. Yellow oil. Rf = 0.18 (4:1, Hexanes:EtOAc). 
1H NMR (500 MHz, Chloroform-d) δ 7.60 (d, J = 8.2 Hz, 1H), 7.49 (t, J = 2.1 Hz, 
1H), 7.38 (t, J = 7.9 Hz, 1H), 7.10 (dd, J = 8.2, 2.7 Hz, 1H), 3.94 (dd, J = 11.9, 4.7 Hz, 
1H), 3.85 (s, 3H), 3.75 (dd, J = 12.2, 8.1 Hz, 1H), 2.53 (dd, J = 8.4, 5.0 Hz, 1H), 2.19 
(bs, 1H), 1.86 – 1.79 (m, 1H), 1.78 – 1.70 (m, 1H), 1.53 – 1.37 (m, 4H), 0.96 – 0.90 
(m, 3H). 
13C NMR (126 MHz, CDCl3) δ 200.0, 159.9, 139.9, 129.7, 120.9, 119.4, 112.5, 60.0, 
55.6, 35.6, 35.4, 30.3, 28.6, 22.3, 13.9. 
IR(neat) 3437, 2957, 2926, 1664, 1586, 1462, 1261, 1034, 778 cm-1 
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3ha (3-fluorophenyl)-2-(hydroxymethyl)-3-propylcyclopropyl)methanone  
 
Y = 54%. Yellow oil. Rf = 0.15 (4:1, Hexanes:EtOAc). 
1H NMR (500 MHz, Chloroform-d) δ 7.79 (dt, J = 7.8, 1.2 Hz, 1H), 7.66 (ddd, J = 9.5, 
2.6, 1.6 Hz, 1H), 7.45 (td, J = 8.0, 5.5 Hz, 1H), 7.29 – 7.23 (m, 2H), 3.95 (dd, J = 
11.9, 4.7 Hz, 1H), 3.73 (dd, J = 11.9, 8.4 Hz, 1H), 2.50 (dd, J = 8.4, 5.0 Hz, 1H), 1.98 
(s, 1H), 1.88 – 1.82 (m, 1H), 1.78 (tdd, J = 8.5, 6.6, 4.7 Hz, 1H), 1.52 – 1.38 (m, 4H), 
0.98 – 0.89 (m, 3H). 
13C NMR (126 MHz, CDCl3) δ 198.8 (d, J = 2.0 Hz), 164.0, 162.0, 130.4 (d, J = 7.7 
Hz), 124.0 (d, J = 3.1 Hz), 120.0 (d, J = 21.6 Hz), 115.0 (d, J = 22.3 Hz), 59.9, 35.9, 
35.34, 30.4, 28.8, 22.4, 14.0. 
19F NMR (282 MHz, Chloroform-d) δ -111.15 (td, J = 9.0, 5.7 Hz). 
IR(neat) 3439, 2958, 2925, 1670, 1588, 1443, 1252, 1030, 785 cm-1 
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3ia (2-fluorophenyl)(2-(hydroxymethyl)-3-propylcyclopropyl)methanone 
 
Y = 44%. Pale-yellow Oil. Rf = 0.19 (4:1 Hexanes:EtOAc).  
1H NMR (300 MHz, Chloroform-d) δ 7.74 (td, J = 7.6, 1.9 Hz, 1H), 7.49 (dddd, J = 
8.5, 7.1, 5.0, 1.9 Hz, 1H), 7.28 – 7.07 (m, 2H), 3.96 (dd, J = 12.0, 4.7 Hz, 1H), 3.78 (t, 
J = 10.1 Hz, 1H), 2.54 (ddd, J = 8.1, 5.1, 2.7 Hz, 1H), 1.95 (s, 1H), 1.89 (ddd, J = 6.5, 
5.1, 1.3 Hz, 1H), 1.77 (tdd, J = 8.3, 6.6, 4.8 Hz, 1H), 1.51 – 1.34 (m, 4H), 0.98 – 0.88 
(m, 3H). 
13C NMR (126 MHz, CDCl3) δ 198.8 (d, J = 3.1 Hz), 161.6 (d, J = 255.0 Hz), 134.2 
(d, J = 9.0 Hz), 130.4 (d, J = 2.6 Hz), 128.0 (d, J = 12.6 Hz), 124.6 (d, J = 3.6 Hz), 
116.8 (d, J = 25.1 Hz), 59.9, 36.3, 35.3, 34.4 (d, J = 7.7 Hz), 29.6, 22.3, 14.0. 
19F NMR (282 MHz, CDCl3) δ -110.33 (dt, J = 8.3, 4.0 Hz). 
IR(neat) 3213, 2956, 2922, 1653, 1607, 1234, 1109, 1036, 834 cm-1 
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3ja 2-(hydroxymethyl)-3-propylcyclopropyl)(naphthalen-2-yl)methanone 
  
Y = 50%. Pale-yellow solid. Rf = 0.18 (4:1 Hexanes:EtOAc).  
1H NMR (500 MHz, Chloroform-d) δ 8.55 (d, J = 1.7 Hz, 1H), 8.05 (dd, J = 8.6, 1.8 
Hz, 1H), 7.98 (d, J = 8.1 Hz, 1H), 7.89 (dd, J = 10.8, 8.3 Hz, 2H), 7.58 (dddd, J = 
21.9, 8.1, 6.8, 1.3 Hz, 2H), 3.99 (dd, J = 12.0, 4.7 Hz, 1H), 3.80 (dd, J = 12.0, 8.3 Hz, 
1H), 2.71 (dd, J = 8.4, 5.0 Hz, 1H), 2.14 (s, 0H), 1.96 – 1.87 (m, 1H), 1.81 (tdd, J = 
8.3, 6.6, 4.7 Hz, 1H), 1.50 (dtd, J = 14.3, 12.8, 11.8, 6.9 Hz, 4H), 0.95 (t, J = 7.0 Hz, 
3H). 
13C NMR (126 MHz, CDCl3) 200.0, 135.9, 135.6, 132.7, 129.8, 129.7, 128.5, 128.5, 
127.9, 126.9, 124.1, 60.1, 35.7, 35.5, 30.3, 28.5, 22.4, 14.0. 
IR(neat) 3300, 2872, 2857, 1657, 1181, 1123, 1046, 1027, 822, 749 cm-1 
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3ka 1-(2-(hydroxymethyl)-3-propylcyclopropyl)-3-phenylpropan-1-one 
 
1H NMR (500 MHz, Chloroform-d) δ 7.31 – 7.26 (m, 2H), 7.21 – 7.18 (m, 3H), 3.90 – 
3.80 (m, 1H), 3.65 (t, J = 10.2 Hz, 1H), 3.02 – 2.88 (m, 4H), 2.01 (s, 1H), 1.83 (dd, J 
= 8.3, 5.0 Hz, 1H), 1.62 (qd, J = 6.6, 4.9 Hz, 1H), 1.53 (tdd, J = 8.2, 6.6, 4.4 Hz, 1H), 
1.42 – 1.28 (m, 3H), 0.89 (t, J = 7.2 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 210.2, 141.2, 128.7, 128.5, 126.3, 59.5, 46.3, 35.3, 
33.1, 30.2, 28.7, 22.3, 13.9. 
IR(neat) 3386, 2958, 2925, 2872, 1689, 1454, 1378, 1034, 733, 700 cm-1 
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3ac (2-(hydroxymethyl)-3-methylcyclopropyl)(phenyl)methanone 
 
Y = 89%. Light yellow solid. Rf = 0.50 (4:1 Hexanes:EtOAc).  
1H NMR (500 MHz, Chloroform-d) δ 8.06 – 7.94 (m, 2H), 7.62 – 7.52 (m, 1H), 7.47 
(dd, J = 8.3, 7.0 Hz, 2H), 3.96 (dd, J = 12.0, 4.7 Hz, 1H), 3.74 (dd, J = 12.0, 8.3 Hz, 
1H), 2.50 (dd, J = 8.4, 5.0 Hz, 1H), 2.17 (s, 1H), 1.84 (h, J = 6.0 Hz, 1H), 1.73 (tdd, J 
= 8.3, 6.4, 4.6 Hz, 1H), 1.26 (d, J = 6.0 Hz, 4H). 
13C NMR (126 MHz, CDCl3) δ 200.3, 138.6, 133.1, 128.7, 128.3, 60.0, 36.5, 31.5, 22.9, 
18.3. 
IR(neat) 3412, 2955, 2889, 1660, 1598, 1219, 1021, 743, 688 cm-1 
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3ad (2-(hydroxymethyl)-2-methylcyclopropyl)(phenyl)methanone 
  
Y = 62% Pale-yellow solid. Rf = 0.19 (4:1 Hexanes:EtOAc) 
 1H NMR (500 MHz, Chloroform-d) δ 8.02 – 7.97 (m, 2H), 7.59 – 7.54 (m, 1H), 7.47 
(dd, J = 8.4, 7.0 Hz, 2H), 3.75 (dd, J = 11.8, 4.6 Hz, 1H), 3.61 (dd, J = 11.8, 5.0 Hz, 
1H), 2.54 (dd, J = 7.8, 5.7 Hz, 1H), 1.89 (t, J = 6.0 Hz, 1H), 1.64 (dd, J = 5.7, 4.3 Hz, 
1H), 1.42 (s, 3H), 1.10 (dd, J = 7.8, 4.3 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 199.7, 138.6, 133.0, 128.7, 128.3, 64.7, 33.3, 31.5, 22.8, 
21.1. 
IR(neat) 3439, 2914, 1669, 1269, 1230, 1022, 714 
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3ae (3-(hydroxymethyl)-2,2-dimethylcyclopropyl)(phenyl)methanone 
 
Y = 82% Pale-yellow oil. Rf = 0.18 (4:1 Hexanes:EtOAc)  
1H NMR (500 MHz, Chloroform-d) δ 7.98 – 7.89 (m, 2H), 7.61 – 7.54 (m, 1H), 7.48 
(dd, J = 8.4, 7.0 Hz, 2H), 4.10 – 4.03 (m, 1H), 4.02 – 3.95 (m, 1H), 2.62 (q, J = 3.8 
Hz, 1H), 2.41 (d, J = 7.9 Hz, 1H), 1.66 (ddd, J = 9.6, 8.0, 6.9 Hz, 1H), 1.41 (s, 3H), 
1.11 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 200.4, 138.8, 133.2, 128.8, 128.3, 59.5, 35.7, 35.6, 28.8, 
28.5, 15.4. 
IR(neat) 3222, 2911, 1668, 1273, 1220, 692 cm-1 
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3af (3-(hydroxymethyl)-2-methyl-2-(4-methylpent-3-en-1-yl)cyclopropyl)(phenyl)methanone 
  
Y = 55%. Colorless oil. Rf = 0.24 (4:1 Hexanes:EtOAc).  
1H NMR (Major) (500 MHz, Chloroform-d) δ 7.99 – 7.89 (m, 2H), 7.61 – 7.51 (m, 
1H), 7.46 (dd, J = 8.5, 7.0 Hz, 2H), 5.13 (tt, J = 6.9, 1.5 Hz, 1H), 4.09 – 3.98 (m, 2H), 
2.45 (d, J = 8.0 Hz, 1H), 2.15 (hept, J = 7.5 Hz, 2H), 1.86 (ddd, J = 13.4, 9.2, 5.9 Hz, 
1H), 1.69 (s, 3H), 1.63 (s, 3H), 1.36 (ddd, J = 13.5, 9.7, 6.8 Hz, 1H), 1.12 (s, 3H). 
13C NMR (Major) (126 MHz, CDCl3) δ 200.3, 138.9, 134.5, 133.1, 132.4, 128.7, 128.3, 
123.8, 123.7, 59.4, 42.9, 35.2, 35.1, 32.5, 25.9, 25.3, 17.9, 12.6. 
IR(neat) 3444, 2923, 1725, 1351, 1282, 1261, 1125, 1053, 964, 910, 759, 698 cm-1 
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3ag (2-(1-hydroxyallyl)cyclopropyl)(phenyl)methanone 
 
Y = 73%. Yellow oil. Rf = 0.22 (4:1 Hexanes:EtOAc).  
1H NMR (500 MHz, Chloroform-d) δ 8.03 (d, J = 7.7 Hz, 2H), 7.56 (t, J = 7.4 Hz, 
1H), 7.47 (t, J = 7.6 Hz, 2H), 6.00 (ddd, J = 16.6, 10.4, 5.6 Hz, 1H), 5.30 (d, J = 17.2 
Hz, 1H), 5.12 (d, J = 10.4 Hz, 1H), 4.06 (dd, J = 9.0, 5.6 Hz, 1H), 2.81 (td, J = 8.1, 5.7 
Hz, 1H), 2.16 (s, 1H), 1.75 (p, J = 8.4 Hz, 1H), 1.49 (q, J = 5.8 Hz, 1H), 1.26 (td, J = 
7.9, 4.5 Hz, 2H). 
13C NMR (126 MHz, CDCl3) δ 199.9, 139.9, 138.6, 133.1, 128.7, 128.4, 114.9, 71.0, 
31.1, 23.1, 13.0.  
IR(neat) 3407, 2889, 1666, 1391, 1224, 1003, 714, 690 cm-1 
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3ah (2-(1-hydroxyethyl)cyclopropyl)(phenyl)methanone 
 
Y = 69%. Off-white solid. Rf = 0.26 (4:1 Hexanes:EtOAc).  
1H NMR (Major) (500 MHz, Chloroform-d) δ 8.08 – 8.02 (m, 2H), 7.60 – 7.53 (m, 
1H), 7.47 (t, J = 7.6 Hz, 2H), 3.74 (dt, J = 12.6, 6.4 Hz, 1H), 2.76 (td, J = 8.2, 5.7 Hz, 
1H), 1.95 (s, 1H), 1.69 (qd, J = 8.7, 6.9 Hz, 1H), 1.43 – 1.35 (m, 1H), 1.33 (d, J = 6.3 
Hz, 3H), 1.25 (td, J = 8.2, 4.4 Hz, 1H). 
13C NMR (Major) (126 MHz, CDCl3) δ 199.9, 138.5, 133.1, 128.7, 128.4, 66.6, 33.0, 
23.4, 23.2, 13.2. 
IR(neat) 3497, 2965, 1666, 1599, 1390, 1210, 999, 699, 690 cm-1 
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3ai (2-(hydroxy(phenyl)methyl)cyclopropyl)(phenyl)methanone 
 
Y = 62%. Light yellow solid. Rf = 0.54 (4:1 Hexanes:EtOAc).  
1H NMR (500 MHz, Chloroform-d) δ 8.17 – 8.06 (m, 2H), 7.61 (t, J = 7.4 Hz, 1H), 
7.56 – 7.47 (m, 4H), 7.39 (t, J = 7.5 Hz, 2H), 7.32 (t, J = 7.3 Hz, 1H), 4.64 (d, J = 9.4 
Hz, 1H), 2.93 (td, J = 8.1, 5.7 Hz, 1H), 2.26 (s, 1H), 2.01 (qd, J = 8.7, 6.9 Hz, 1H), 
1.64 (dt, J = 6.8, 5.0 Hz, 1H), 1.26 (dt, J = 8.2, 4.1 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 199.6, 144.0, 138.6, 133.0, 128.7, 128.6, 128.4, 127.7, 
126.0, 72.1, 33.0, 23.8, 13.4. 
IR(neat) 3495, 2944, 1669, 1591, 1390, 1223, 1210, 1010, 699 cm-1 
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3aj (2-(1-hydroxyethyl)-3-methylcyclopropyl)(phenyl)methanone 
 
Y = 88% Pale-yellow oil. Rf = 0.19 (4:1 Hexanes:EtOAc) 
1H NMR (500 MHz, Chloroform-d) δ 8.05 – 7.98 (m, 2H), 7.60 – 7.53 (m, 1H), 7.51 – 
7.43 (m, 2H), 3.87 (dq, J = 8.8, 6.3 Hz, 1H), 2.47 (dd, J = 8.4, 5.1 Hz, 1H), 2.23 (s, 
1H), 1.74 (td, J = 6.3, 5.2 Hz, 1H), 1.50 (td, J = 8.6, 6.4 Hz, 1H), 1.32 (d, J = 6.3 Hz, 
3H), 1.24 (d, J = 6.1 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 200.2, 138.6, 133.0, 128.7, 128.7, 128.7, 128.2, 66.0, 
42.2, 32.0, 23.2, 23.1, 18.2. 
IR(neat) 3214, 2975, 1735, 1602, 1224, 1115, 1062, 905, 732, 715 cm-1 
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3ak (2-(hydroxy(phenyl)methyl)-3-propylcyclopropyl)(phenyl)methanone 
 
Y = 75%. Off-white solid. Rf = 0.34 (4:1 Hexanes:EtOAc). 
1H NMR (500 MHz, Chloroform-d) δ 8.09 – 8.02 (m, 2H), 7.61 – 7.54 (m, 1H), 7.52 – 
7.42 (m, 4H), 7.36 (t, J = 7.6 Hz, 2H), 7.31 – 7.24 (m, 1H), 4.77 (dd, J = 9.2, 3.7 Hz, 
1H), 2.66 (dd, J = 8.4, 5.1 Hz, 1H), 2.28 (d, J = 3.8 Hz, 1H), 1.99 (qd, J = 6.6, 5.0 Hz, 
1H), 1.81 (td, J = 8.9, 6.5 Hz, 1H), 1.48 – 1.37 (m, 1H), 1.31 – 1.26 (m, 1H), 1.22 
(ddtd, J = 12.6, 8.1, 6.7, 6.3, 4.4 Hz, 2H), 0.77 (t, J = 7.2 Hz, 3H).  
13C NMR (126 MHz, CDCl3) δ 199.8, 144.1, 138.7, 132.9, 128.7, 128.6, 127.6, 126.0, 
71.6, 41.3, 35.2, 31.2, 28.6, 22.1, 13.8. 
IR(neat) 3437, 2958, 2923, 1666, 1587, 1442, 1251, 1032, 908, 730 cm-1 
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3al (2-(cyclohexyl(hydroxy)methyl)-3-propylcyclopropyl)(phenyl)methanone 
 
Y = 95%. Off-white solid. Rf = 0.54 (4:1 Hexanes:EtOAc).  
1H NMR (500 MHz, Chloroform-d) δ 8.06 – 7.97 (m, 2H), 7.54 (t, J = 7.5 Hz, 1H), 
7.45 (t, J = 7.6 Hz, 2H), 3.41 (dd, J = 9.2, 6.6 Hz, 1H), 2.49 (dd, J = 8.7, 5.0 Hz, 1H), 
1.99 – 1.86 (m, 2H), 1.86 – 1.80 (m, 1H), 1.80 – 1.71 (m, 3H), 1.62 (dtq, J = 12.8, 
10.2, 3.8, 2.9 Hz, 3H), 1.43 (dt, J = 14.8, 7.4 Hz, 3H), 1.32 – 1.15 (m, 4H), 1.15 – 1.00 
(m, 2H), 0.92 (t, J = 7.3 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 200.3, 138.8, 132.8, 128.6, 128.3, 73.7, 44.4, 38.8, 35.4, 
29.3, 29.0, 26.7, 26.4, 26.3, 22.2, 14.1. 
IR(neat) 3438, 2922, 2851, 1656, 1451, 1232, 1020, 711, 685, 660 cm-1 
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3an (2-hydroxybicyclo[6.1.0]nonan-9-yl)(phenyl)methanone 
 
Y = 85%. Colorless oil. Rf = 0.05 (4:1 Hexanes:EtOAc) 
1H NMR (500 MHz, Chloroform-d) δ 8.10 – 7.98 (m, 2H), 7.57 (t, J = 7.4 Hz, 1H), 
7.47 (t, J = 7.6 Hz, 2H), 4.13 (td, J = 10.9, 4.6 Hz, 1H), 3.14 (s, 1H), 2.58 (dd, J = 9.6, 
7.7 Hz, 1H), 1.91 (tt, J = 12.0, 4.3 Hz, 1H), 1.77 (tdd, J = 17.0, 8.4, 4.2 Hz, 3H), 1.73 
– 1.65 (m, 2H), 1.59 (ddt, J = 15.3, 12.2, 4.3 Hz, 1H), 1.49 (tdd, J = 13.6, 10.4, 4.4 
Hz, 1H), 1.45 – 1.30 (m, 2H), 1.21 (tdd, J = 14.3, 8.0, 3.6 Hz, 2H). 
13C NMR (126 MHz, CDCl3) δ 200.3, 138.4, 133.4, 128.7, 128.6, 67.7, 36.7, 30.4, 29.8, 
27.0, 26.6, 26.2, 25.1, 24.5. 
IR(neat) 3446, 2924, 2854, 1660, 1448, 1394, 1212, 1050, 1011, 956, 718 cm-1 
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A2.4 Mechanistic Experiments 
 
Deuterated allylic alcohol–Retention of stereochemistry at the alkene 
 
N-enoxyphthalimide 1a (0.12 mmol), catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.006 mmol, 
4.4 mg), and KOPiv (2 equiv., 0.24 mmol, 33.6 mg) were weighed in a 1-dram vial with 
a magnetic stirbar. Cooled TFE (0.2 M, 600 µL) was added followed by allylic alcohol 
2a-d1 (1.2 equiv., 0.144 mmol). The vial was sealed with a screw-cap and placed in an 
aluminium block cooled to 0 ˚C surrounded by ice in an insulated box and stirred for 
16 hours. Upon completion judged by TLC, TFE was removed by rotary evaporation 
and the residue was taken up in EtOAc and filtered through a silica plug flushing with 
EtOAc. The filtrate was concentrated to ~1mL and transferred to a 1.5-dram vial where 
the solution was partitioned with the addition of 10% NaOH solution. The aqueous 
layer was extracted three times with EtOAc and the combined organic extracts were 
filtered through a pad of celite® and Na2SO4 then concentrated. The residue was 
purified by flash chromatography (Hexane:EtOAc, 19:1®9:1®4:1) to afford the 
cyclopropane product. 
[Cp*CF3RhCl2]2 (5 mol%)
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3aa’ 2-(hydroxymethyl)-3-propylcyclopropyl-2-d)(phenyl)methanone 
 
Y = 82%. Colorless Oil. Rf = 0.22 (4:1 Hexanes:EtOAc).  
1H NMR (500 MHz, Chloroform-d) δ 8.05 – 7.97 (m, 2H), 7.62 – 7.55 (m, 1H), 7.49 
(dd, J = 8.4, 7.0 Hz, 2H), 3.96 (d, J = 12.0 Hz, 1H), 3.77 (d, J = 12.0 Hz, 1H), 2.56 (d, 
J = 5.0 Hz, 1H), 2.21 (s, 1H), 1.86 (q, J = 6.2 Hz, 1H), 1.48 (ttd, J = 11.8, 5.8, 5.1, 2.5 
Hz, 4H), 0.99 – 0.92 (m, 3H). 
13C NMR (126 MHz, CDCl3) δ 199.6, 144.0, 138.6, 133.0, 128.7, 128.6, 128.4, 127.7, 
126.0, 72.1, 33.0, 23.8, 13.4. 
IR(neat) 3458, 2921, 1657, 1450, 1228, 1020, 699 cm-1 
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Assignment of stereochemistry 
 
The assignment of the major diastereomer for the substrates presented in this work 
was determined by analogy of this result. When 2a-d1 is subjected to the reaction 
conditions, the resulting cyclopropane 3aa’ is characterized by coupling constants of 
the a-hydrogen to the phenyl ketone (highlighted in red) that gives a doublet in the 
1H-NMR spectrum. Assuming retention of stereochemistry at the alkene, if the 
hydroxymethyl substituent is trans to the ketone, the blue proton from the alkene 
should be cis to the ketone and give a large J value. Alternatively, if the hydroxymethyl 
substituent is cis to the ketone, the blue proton from the alkene should be trans to the 
ketone and give a small J value. We observe the doublet of the a-hydrogen to have a J 
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N-enoxyphthalimide 1a (0.12 mmol), catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.006 mmol, 
4.4 mg), and KOPiv (2 equiv., 0.24 mmol, 33.6 mg) were weighed in a 1-dram vial with 
a magnetic stirbar. Cooled TFE (0.2 M, 600 µL) was added. The vial was sealed with a 
screw-cap and placed in an aluminium block cooled to 0 ˚C surrounded by ice in an 
insulated box and stirred for 3 hours. TFE-d1 was removed by rotary evaporation and 
the residue was taken up in EtOAc and filtered through a silica plug flushing with 
EtOAc. The filtrate was concentrated to ~1mL and transferred to a 1.5-dram vial where 
the solution was partitioned with the addition of 10% NaOH solution. The aqueous 
layer was extracted three times with EtOAc and the combined organic extracts were 
filtered through a pad of celite® and Na2SO4 then concentrated. The residue was 









KOPiv ( 2 equiv.)
TFE-d1, 0 ˚C
1a      0% D1a
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With homoallylic alcohol 4a 
 
 
N-enoxyphthalimide 1a (0.12 mmol), catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.006 mmol, 
4.4 mg), and KOPiv (2 equiv., 0.24 mmol, 33.6 mg) were weighed in a 1-dram vial with 
a magnetic stirbar. Cooled TFE (0.2 M, 600 µL) was added followed by homoallylic 
alcohol 4a (1.2 equiv., 0.144 mmol). The vial was sealed with a screw-cap and placed 
in an aluminium block cooled to 0 ˚C surrounded by ice in an insulated box and stirred 
for 16 hours. Upon completion judged by TLC, TFE was removed by rotary evaporation 
and the residue was taken up in EtOAc and filtered through a silica plug flushing with 
EtOAc. The filtrate was concentrated to ~1mL and transferred to a 1.5-dram vial where 
the solution was partitioned with the addition of 10% NaOH solution. The aqueous 
layer was extracted three times with EtOAc and the combined organic extracts were 
filtered through a pad of celite® and Na2SO4 then concentrated. Yield and 
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With bis-homoallylic alcohol 
 
 
N-enoxyphthalimide 1a (0.12 mmol), catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.006 mmol, 
4.4 mg), and KOPiv (2 equiv., 0.24 mmol, 33.6 mg) were weighed in a 1-dram vial with 
a magnetic stirbar. Cooled TFE (0.2 M, 600 µL) was added followed by bis-homoallylic 
alcohol 6a (1.2 equiv., 0.144 mmol). The vial was sealed with a screw-cap and placed 
in an aluminium block cooled to 0 ˚C surrounded by ice in an insulated box and stirred 
for 16 hours. Upon completion judged by TLC, TFE was removed by rotary evaporation 
and the residue was taken up in EtOAc and filtered through a silica plug flushing with 
EtOAc. The filtrate was concentrated to ~1mL and transferred to a 1.5-dram vial where 
the solution was partitioned with the addition of 10% NaOH solution. The aqueous 
layer was extracted three times with EtOAc and the combined organic extracts were 
filtered through a pad of celite® and Na2SO4 then concentrated. Yield and 
















	 - 185 - 
With allylic ether 6a 
 
 
N-enoxyphthalimide 1a (0.12 mmol), catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.006 mmol, 
4.4 mg), and KOPiv (2 equiv., 0.24 mmol, 33.6 mg) were weighed in a 1-dram vial with 
a magnetic stirbar. Cooled TFE (0.2 M, 600 µL) was added followed by allylic ether 8a 
(1.2 equiv., 0.144 mmol). The vial was sealed with a screw-cap and placed in an 
aluminium block cooled to 0 ˚C surrounded by ice in an insulated box and stirred for 
16 hours. Upon completion judged by TLC, TFE was removed by rotary evaporation 
and the residue was taken up in EtOAc and filtered through a silica plug flushing with 
EtOAc. The filtrate was concentrated to ~1mL and transferred to a 1.5-dram vial where 
the solution was partitioned with the addition of 10% NaOH solution. The aqueous 
layer was extracted three times with EtOAc and the combined organic extracts were 
filtered through a pad of celite® and Na2SO4 then concentrated. Yield and 
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With allylic carboxylic acid 
 
 
N-enoxyphthalimide (0.12 mmol), catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.006 mmol, 4.4 
mg), and KOPiv (2 equiv., 0.24 mmol, 33.6 mg) were weighed in a 1-dram vial with a 
magnetic stirbar. Cooled TFE (0.2 M, 600 µL) was added followed by allylic carboxylic 
acid (1.2 equiv., 0.144 mmol). The vial was sealed with a screw-cap and placed in an 
aluminium block cooled to 0 ˚C surrounded by ice in an insulated box and stirred for 
16 hours. Upon completion judged by TLC, TFE was removed by rotary evaporation 
and the residue was taken up in EtOAc and filtered through a silica plug flushing with 
EtOAc. The filtrate was concentrated to ~1mL and transferred to a 1.5-dram vial where 
the solution was partitioned with the addition of 10% NaOH solution. The aqueous 
layer was extracted three times with EtOAc and the combined organic extracts were 
filtered through a pad of celite® and Na2SO4 then concentrated. Yield and 
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With allylic amine 
 
N-enoxyphthalimide (0.12 mmol), catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.006 mmol, 4.4 
mg), and KOPiv (2 equiv., 0.24 mmol, 33.6 mg) were weighed in a 1-dram vial with a 
magnetic stirbar. Cooled TFE (0.2 M, 600 µL) was added followed by allylic amine (1.2 
equiv., 0.144 mmol). The vial was sealed with a screw-cap and placed in an aluminium 
block cooled to 0 ˚C surrounded by ice in an insulated box and stirred for 16 hours. 
Upon completion judged by TLC, TFE was removed by rotary evaporation and the 
residue was taken up in EtOAc and filtered through a silica plug flushing with EtOAc. 
The filtrate was concentrated to ~1mL and transferred to a 1.5-dram vial where the 
solution was partitioned with the addition of 10% NaOH solution. The aqueous layer 
was extracted three times with EtOAc and the combined organic extracts were filtered 
through a pad of celite® and Na2SO4 then concentrated. The crude residue was purified 
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9ac N-((2-benzoyl-3-propylcyclopropyl)methyl)-4-methylbenzenesulfonamide 
 
Y = 77%. Off-White Solid. Rf = 0.21 (4:1 Hexanes:EtOAc).  
1H NMR (500 MHz, Chloroform-d) δ 7.91 (dd, J = 8.3, 1.3 Hz, 2H), 7.66 (d, J = 8.2 
Hz, 2H), 7.60 – 7.53 (m, 1H), 7.46 (t, J = 7.7 Hz, 2H), 7.25 (d, J = 8.0 Hz, 2H), 4.65 
(t, J = 6.4 Hz, 1H), 3.37 (ddd, J = 14.0, 6.9, 5.6 Hz, 1H), 3.11 (ddd, J = 14.3, 8.8, 5.9 
Hz, 1H), 2.49 (dd, J = 8.4, 5.0 Hz, 1H), 2.40 (s, 3H), 1.71 (tt, J = 8.6, 6.0 Hz, 1H), 
1.67 – 1.60 (m, 1H), 1.42 – 1.30 (m, 4H), 0.94 – 0.85 (m, 3H). 
13C NMR (126 MHz, CDCl3) δ 199.3, 143.4, 134.5, 133.2, 129.8, 128.8, 128.2, 127.2, 
123.8, 41.3, 35.1, 33.0, 29.8, 29.7, 22.3, 21.7, 13.9. 
IR(neat) 3520, 3189, 3061, 1666, 1602, 1373, 1305, 1239, 1159, 1049, 711, 647. 
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With NaH 
 
N-enoxyphthalimide 1a (0.12 mmol) and catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.006 
mmol, 4.4 mg), were weighed in a 1-dram vial with a magnetic stirbar. Cooled TFE 
(0.2 M, 600 µL) was added followed by allylic alcohol 6a (1.2 equiv., 0.144 mmol). The 
vial was sealed with a screw-cap and placed in an aluminium block cooled to 0 ˚C 
surrounded by ice in an insulated box and stirred for 2 mins. The vial was removed and 
NaH (2 equiv., 0.24 mmol) was added and vigorous bubbling occurred. The vial was 
placed back in the cooling block at 0 °C and stirred for 16 hours. Upon completion 
judged by TLC, TFE was removed by rotary evaporation and the residue was taken up 
in EtOAc and filtered through a silica plug flushing with EtOAc. The filtrate was 
concentrated to ~1mL and transferred to a 1.5-dram vial where the solution was 
partitioned with the addition of 10% NaOH solution. The aqueous layer was extracted 
three times with EtOAc and the combined organic extracts were filtered through a pad 
of celite® and Na2SO4 then concentrated. Yield and diastereoselectivity were 
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Isolation of off-cycle intermediate 
 
N-enoxyphthalimide 1a (0.75 mmol) and KOPiv (1 equiv., 0.75 mmol) were weighed 
in a 1-dram vial with a magnetic stirbar. THF (0.2 M, 3.770 mL) was added followed by 
allylic alcohol 2b (1.2 equiv., 0.91 mmol). The vial was sealed with a screw-cap and 
stirred for 16 hours at room temperature. THF was removed by rotary evaporation and 
the crude residue was purified by flash chromatography (Hexane:EtOAc, 19:1) to 
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10ac (E)-but-2-en-1-yl 2-(5-methyl-5-phenyl-1,4,2-dioxazol-3-yl)benzoate 
 
Y=38% Colorless Oil. Rf = 0.64 (4:1 Hexanes:EtOAc). 
1H NMR (500 MHz, Chloroform-d) δ 7.80 – 7.74 (m, 1H), 7.71 – 7.65 (m, 1H), 7.62 – 
7.58 (m, 2H), 7.56 – 7.50 (m, 2H), 7.44 – 7.37 (m, 3H), 5.81 (dqt, J = 15.3, 6.4, 1.2 
Hz, 1H), 5.59 (dtq, J = 14.8, 6.5, 1.6 Hz, 1H), 4.68 (ddt, J = 12.3, 6.5, 1.2 Hz, 1H), 
4.61 (ddt, J = 12.2, 6.5, 1.1 Hz, 1H), 2.01 (s, 3H), 1.71 (dq, J = 6.5, 1.2 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 166.96, 158.13, 140.15, 132.41, 132.01, 131.28, 131.24, 
129.99, 129.63, 129.30, 128.57, 125.22, 124.85, 122.70, 116.05, 66.62, 25.70, 17.98. 
IR(neat) 2973, 1726, 1282, 1261, 1121, 910, 759, 697 cm-1 
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Dioxazoline 10ac (0.12 mmol), catalyst [Cp*CF3RhCl2]2 (5 mol%, 0.006 mmol, 4.4 mg), 
and KOPiv (2 equiv., 0.24 mmol, 33.6 mg) were weighed in a 1-dram vial with a 
magnetic stirbar. Cooled (or room temperature) TFE (0.2 M, 600 µL) was added. The 
vial was sealed with a screw-cap and placed in an aluminium block cooled to 0 ˚C 
surrounded by ice in an insulated box (or placed on a stir plate at room temperature) 
and stirred for 16 hours. TFE was removed by rotary evaporation and the residue was 
taken up in EtOAc and filtered through a silica plug flushing with EtOAc. The filtrate 
was concentrated to ~1mL and transferred to a 1.5-dram vial where the solution was 
partitioned with the addition of H2O. The aqueous layer was extracted three times with 
EtOAc and the combined organic extracts were filtered through a pad of celite® and 
















KOPiv ( 2 equiv.)
TFE, 0 or 21 ˚C
3ac   not observed




N-enoxyphthalimide 1aa’ (0.06 mmol) and KOPiv (2 equiv., 0.12 mmol) were weighed 
in a 1-dram vial with a magnetic stirbar. TFE-d3 (0.1 M, 600 mL) was added followed 
by allylic alcohol 2c (1.7 equiv., 0.10 mmol). The vial was sealed with a screw-cap and 
stirred briefly and the solution transferred to an NMR tube and injected in the 
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-Stereochemistry retained at alkene
-Steric clash avoided with Cp
-Substituent is equatorial
-Minor Diastereomer
-Stereochemistry retained at alkene
-Steric clash with Cp
-Substituent is axial
-Minor Diastereomer
-Stereochemistry retained at alkene
-Steric clash with Cp
-Substituent is equatorial
-Minor Diastereomer
-Stereochemistry retained at alkene
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A2.6 X-Ray Data 
 
Single crystal X-ray diffraction. Data for all compounds was collected on an Agilent 
SuperNova diffractometer using mirror-monochromated Cu Ka radiation. Data 
collection, integration, scaling (ABSPACK) and absorption correction (face-indexed 
Gaussian integration12 or numeric analytical methods13) were performed in 
CrysAlisPro.14 Structure solution was performed using ShelXT15. Subsequent 
refinement was performed by full-matrix least-squares on F2 in ShelXL.16 Olex217 was 
used for viewing and to prepare CIF files. PLATON18 was used extensively for 
CheckCIF. ORTEP graphics were prepared in CrystalMaker.19 Thermal ellipsoids are 
rendered at the 50% probability level.  
 
A solution of EJTP2213_B_pure in CHCl3/hexanes was slowly evaporated to afford 
long, colorless needles. Part of a crystal (.46 x .06 x .04 mm) was separated carefully, 
mounted on a glass fiber with Paratone oil, and cooled to 100 K on the diffractometer. 
Complete data were collected to 0.8 Å. 12900 reflections were collected (2666 unique, 
2373 observed) with R(int) 5.9% and R(sigma) 4.2% after Gaussian absorption and 
beam profile correction (maximum correction factor 1.46).  
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The space group was assigned tentatively as I2/a based on the systematic absences. 
Using ShelXT, the structure solved readily in I2/a with 1 molecule in the asymmetric 
unit. All non-H atoms were located in the initial solution and refined anisotropically 
with no restraints. The O-H hydrogen was located in a difference map and refined with 
unrestrained coordinates and isotropic ADP. C-H hydrogens were placed in calculated 
positions and refined with riding coordinates and ADPs.  
 
The final refinement (2666 data, 0 restraints, 176 parameters) converged with R1 (Fo > 
4σ(Fo)) = 4.6%, wR2 = 12.1%, S = 1.04. The largest Fourier features were 0.25 and -
0.20 e- A-3.  
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Molecular structure of EJTP2213_B_pure. The crystal is centrosymmetric and thus 
contains both enantiomers. 
  






Space group I2/a 
a (Å) 20.0490(6) 
b (Å) 5.46156(14) 
c (Å) 25.6163(8) 
α (°) 90 
β (°) 107.386(3) 
γ (°) 90 
V (Å3) 2676.80(14) 
Z 8 
ρcalc (g cm-3) 1.252 
  
T (K) 100 
λ (Å) 1.54184 
2θmin, 2θmax 7, 146 
Nref 12900 
R(int), R(σ) .0591, .0416 
μ(mm-1) 0.642 
Size (mm) .46 x .06 x .04 
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Me
O OH
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– Appendix C – 




In a flame-dried 1-dram vial equipped with a magnetic stir bar, 4-1a (5 equiv.), 
[Cp*CF3RhCl2]2 (1 equiv.), KOPiv (2 equiv.) were added and weighed in air. 2,2,2-
trifluoroethanol (TFE) (0.2M) was added via micropipette and the vial was sealed with 
a teflon cap. The atmosphere was then replaced with ethylene gas and stirred at room 
temperature overnight. TFE was removed and the crude residue was purified by flash 
chromatography with silica eluting with Hexanes: Ethyl Acetate (9:1 to 4:1) giving the 
desired metal complex an orange oil. A crystal was grown by taking up 4-4 in DCM and 
layering pentane on top and letting the vial rest in the freezer (~-20 °C) overnight. The 
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Yield: 83% 
1H NMR (400 MHz, Chloroform-d) δ 8.21 – 8.14 (m, 2H), 7.60 – 7.43 (m, 3H), 5.37 – 
5.26 (m, 1H), 4.78 (d, J = 10.2 Hz, 1H), 4.35 (d, J = 7.3 Hz, 1H), 3.61 (d, J = 12.4 Hz, 
1H), 2.00 (d, J = 1.3 Hz, 3H), 1.58 (s, 3H), 1.49 (d, J = 1.1 Hz, 3H), 1.28 (s, 3H). 
19F NMR (282 MHz, CDCl3) δ -53.36  







	 - 258 - 
 
 In a flame-dried 1-dram vial equipped with a magnetic stir bar, 5-5a (2 equiv.), 
[Cp*MCl2]2 (0.5 equiv.), AgOAc (2 equiv.) were added and weighed in air. Methanol 
(0.2M) was added via micropipette and the vial was sealed with a teflon cap. The vial 
was then put in an aluminum heating block and stirred at 65 °C overnight. After letting 
the reaction cool, methanol was removed and the crude residue was purified by flash 
chromatography with silica eluting with DCM:MeOH (1% to 3% to 5%) giving the 



















MeOH (0.2M), 65 °C
(2 equiv.)
5-5a
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Yield: 61% 
1H NMR (500 MHz, Chloroform-d) δ 7.88 – 7.83 (m, 1H), 7.60 – 7.55 (m, 1H), 7.45 – 
7.36 (m, 2H), 7.30 (q, J = 5.6 Hz, 1H), 3.82 (s, 3H), 2.46 (d, J = 5.7 Hz, 3H), 1.69 (s, 
17H). 
13C NMR (126 MHz, Chloroform-d) δ 177.8, 169.7, 155.8, 133.4, 132.0, 130.4, 130.4, 
129.7, 128.3, 85.2, 52.4, 18.2, 8.9 
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